WO2013015504A1 - Method for deglycyrrhizinating liquorice, deglycyrrhizinated liquorice extracts and method for preparing same, and anti-caries composition - Google Patents

Method for deglycyrrhizinating liquorice, deglycyrrhizinated liquorice extracts and method for preparing same, and anti-caries composition Download PDF

Info

Publication number
WO2013015504A1
WO2013015504A1 PCT/KR2012/000766 KR2012000766W WO2013015504A1 WO 2013015504 A1 WO2013015504 A1 WO 2013015504A1 KR 2012000766 W KR2012000766 W KR 2012000766W WO 2013015504 A1 WO2013015504 A1 WO 2013015504A1
Authority
WO
WIPO (PCT)
Prior art keywords
licorice
extract
porous resin
extraction
resin adsorbent
Prior art date
Application number
PCT/KR2012/000766
Other languages
French (fr)
Korean (ko)
Inventor
김형준
Original Assignee
주식회사 닥터앤푸드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 닥터앤푸드 filed Critical 주식회사 닥터앤푸드
Publication of WO2013015504A1 publication Critical patent/WO2013015504A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • A23L5/23Removal of unwanted matter, e.g. deodorisation or detoxification by extraction with solvents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Definitions

  • the present invention relates to a method for removing glycyrrhizine of licorice, a licorice extract from which glycyrigin has been removed, and a method for preparing the same, and more particularly, to extracting licorice from hot water and solvent extraction, and then using the porous resin adsorbent.
  • the present invention relates to a method for removing glycyrrhizine of licorice, which is capable of effectively removing glycyrizine in licorice, and to a method for preparing licorice extract from which glycyridin has been removed, and an anti-carbohydrate composition comprising the licorice extract from which glycisgin is removed.
  • Tooth decay is a bacterial dental disease that causes the decay of dental tissue by demineralizing the minerals in the teeth and destroying dentin by causing bacteria in the oral cavity, especially Streptococcus mutans. It is reported to have.
  • tooth decay occurs when three conditions exist: teeth, mutans, and carbohydrates.
  • Mutans bacteria decompose sucrose, an energy source, to be used for growth, and produce glucose and fructose using sucrose as a substrate.
  • Glucose produced is reported to be a major cause of forming plaque, which is an attachment group of microorganisms.
  • Korean Patent No. 10-0454226 discloses a method for preparing licorice extract that inhibits the growth and activity of cavities and a functional anti-cavity material containing licorice extract.
  • licorice extract contains a large amount of glycyrrhizin (glycyrrhizin), which exhibits side effects in the human body, along with components that inhibit the activity of caries.
  • glycyrazine is known to have side effects such as hypertension, edema, hypokalemia, hyporeninemia and the like.
  • glycyrrhizin should be removed.
  • glycyrrhigin is removed by hydrothermal extraction.
  • an object of the present invention is to provide a method for removing glycyrrhizine of licorice which can effectively remove glycyrrhizine in licorice.
  • the present invention provides an anti-carbohydrate composition
  • a licorice extract having an excellent antimicrobial activity (anti-cariogenic performance) without the side effect caused by glycyrrhizin effectively removed, and a method for preparing the same There is a purpose.
  • a method for removing glycyrrhizine of licorice comprising a desorption step of separating the licorice extract adsorbed on the porous resin adsorbent from the porous resin adsorbent.
  • It provides a licorice extract comprising a desorption step of separating the licorice extract adsorbed on the porous resin adsorbent from the porous resin adsorbent.
  • the dilution solvent is added to the licorice extract obtained by the second extraction and diluted, and then contacted with a porous resin adsorbent.
  • the adsorption step includes the steps of: (a) diluting the licorice extract obtained by the second extraction with water, followed by primary contact with a porous resin adsorbent; And (b) adding 30 to 60% by weight of an ethanol aqueous solution to the first contacted licorice extract, followed by dilution, followed by a second contact with a porous resin adsorbent.
  • licorice extract is preferably separated from the porous resin adsorbent using a dilute solvent, preferably 70 to 98% by weight of an ethanol aqueous solution.
  • the present invention provides a licorice extract, which is prepared according to the preparation method and whose content of glycyrrhizine is 1.0 wt% or less.
  • the present invention provides an anti-cavities composition comprising the licorice extract.
  • a licorice extract from which glycyrizine is effectively removed by adsorption and separation through a porous resin adsorbent can be obtained. It is possible to obtain an anti-cavity composition that can be used without any worry.
  • FIG. 1 is a graph showing the results of the antimicrobial evaluation of licorice extract prepared according to an embodiment of the present invention.
  • Figure 2 is a graph showing the growth inhibition evaluation results of Streptococcus mutans (S.mutans) bacteria in the presence of glucose (glucose) of the licorice extract prepared according to an embodiment of the present invention.
  • Figure 3 is a graph showing the results of growth inhibition evaluation of Streptococcus mutans (S.mutans) in the presence of sucrose (sucrose) of the licorice extract prepared according to an embodiment of the present invention.
  • the glycyrrhizin removal method of licorice includes a first extraction step of extracting hot water from licorice; A second extraction step of filtering the mixture of licorice and extract obtained by the first extraction to separate licorice, adding an organic solvent to the separated licorice, and then heating and extracting it; An adsorption step of filtering the mixture of licorice and extract obtained by the second extraction to separate the extract and then adsorbing the separated extract with a hydrophobic porous resin adsorbent to adsorb pharmacologically active ingredients; And a desorption step of contacting the porous resin adsorbent, to which the pharmacologically active active ingredient is adsorbed, with a solvent so as to dissolve the pharmacologically active active ingredient in a solvent.
  • glycyrrhizine is effectively removed from the licorice extract, which is the finally obtained pharmacologically active ingredient, in an amount of 1% by weight or less, preferably 0% by weight.
  • the detailed description of each step is as follows.
  • Licorice to be extracted in the present invention is preferably the root of licorice.
  • the root of licorice is good to be dried, for example, it is crushed to the size of 0.2 ⁇ 5cm, it can be used to crushed to the size of 50 ⁇ m ⁇ 1mm.
  • hot water is extracted from the above licorice (root). This hydrothermal extraction primarily removes glycyrazine along with foreign matter. Although it does not specifically limit, It is preferable to mix 10 to 30 times the weight of licorice with licorice, and to heat-extract hot water at 40-150 degreeC. At this time, when the hot water extraction temperature is less than 40 ° C, the elubility of glycyrrhizine may be insignificant, and when it exceeds 150 ° C, pharmacologically active active ingredients such as anti-cavities components may be extracted. In view of this point, the hot water extraction temperature is more preferably 60 to 120 ° C.
  • the hot water extraction may be performed, for example, for 10 minutes to 3 hours. If the hydrothermal extraction time is too short, less than 10 minutes, the solubility of glycyrizine may be insignificant, and if it is too long for more than 3 hours, the synergistic effect of the excess time may not be so great and undesirable in terms of energy cost.
  • hot water extraction is one or more times. Preferably, while proceeding within the temperature range and time range, the extraction is repeated three or more times under normal pressure in terms of the removal efficiency of glycyrazine. For example, it is good to extract 3 to 5 times at normal pressure.
  • hot water extraction can be extracted by immersing licorice root in the container of a network structure, for example, immersing in the container containing water.
  • an organic solvent is added to the separated licorice, and then the mixture of the licorice and the organic solvent is heated to solvent extraction. That is, after hot water extraction, licorice and the extract (filtrate containing glycyrrhizine) are filtered through filter paper or the like, and the licorice is separated by filtration. The organic liquor is mixed with the separated licorice and then extracted again. At this time, glycyrrhizin contained in the extract may be recovered through a purification process.
  • the organic solvent is not limited.
  • the organic solvent may include one or more selected from, for example, ethanol, methanol, butanol, propanol, ethyl acetate, acetone, chloroform, nucleic acid and the like, and preferably includes ethanol.
  • ethanol methanol, butanol, propanol, ethyl acetate, acetone, chloroform, nucleic acid and the like
  • 30-98 weight% of ethanol aqueous solution can be used specifically ,.
  • the organic solvent for example, ethanol
  • heat-extract the solvent at 30-100 degreeC.
  • an extract containing pharmacologically active active ingredients such as anti-cavities components is extracted.
  • the organic solvent is used less than 5 times the weight of licorice, sufficient extraction may not be made.
  • the amount of the organic solvent used is more than 30 times, the synergistic effect of using the excess solvent is not very large, and the concentration time may be long.
  • the extraction temperature is less than 30 ° C, the dissolution properties of the active ingredient (anti-cause components, etc.) may be insignificant, and when the extraction temperature exceeds 100 ° C, the volatility of the organic solvent may increase. In view of this point, it is more preferable to add an organic solvent at 10-20 times the weight of licorice and extract it at a temperature of 50-90 ° C.
  • the said solvent extraction time is 10 minutes-4 hours, for example. If the extraction time is too short, less than 10 minutes, the elutability of the active ingredient may be insignificant, and if the extraction time is too long over 4 hours, the synergistic effect of the excess time is not so large and may be undesirable in terms of energy costs.
  • the solvent extraction is preferably performed at least once under reduced pressure. Preferably, while proceeding within the temperature range and time range, it is good to extract at least once under a pressure of 10 ⁇ 700 Torr.
  • an extract obtained by extracting pharmacologically active active ingredients such as anti-cavities components contained in licorice is obtained.
  • the extract thus obtained is subjected to the adsorption step described below. That is, after the solvent extraction (secondary extraction) as described above, licorice (licorice foil) and the extract liquid is separated through a filter paper, etc., the separated extract is subjected to the adsorption step below. At this time, the obtained extract may be subjected to the following adsorption step after being concentrated or diluted in some cases.
  • the extract obtained through the secondary extraction is contacted with a porous resin adsorbent.
  • a batch type or a continuous flow type may be used.
  • the extract and the porous resin adsorbent may be put together in a vessel provided with a stirrer and contacted by a batch method.
  • the porous resin adsorbent can be contacted by adding, for example, 10 to 100 times the weight of the extract.
  • the porous resin adsorbent is packed into the column, and then the extract is contacted (adsorption) by continuously passing the extract through the column filled with the porous resin adsorbent. It is good to let.
  • the continuous flow type using the column a large amount of the extract liquid can be continuously contacted within a shorter time than the batch type, so the efficiency is good.
  • glycyrrhizin is secondarily separated and removed, thereby obtaining a licorice extract which is a pharmacologically active ingredient in which glycyrrhizin is effectively removed. That is, the extract obtained through the solvent extraction (secondary extraction) contains a small amount of glycyrrhizin together with the pharmacologically active active ingredients such as anti-cavities components, wherein the pharmacologically active active ingredients such as the anti-cavities components included in the extract are porous
  • the glycyrrhizine adsorbed by the resin adsorbent and remaining in the extract is separated and removed.
  • the porous resin adsorbent may be used to selectively adsorb a hydrophobic material.
  • the hydrophobic pharmacologically active active ingredient is adsorbed onto the porous resin adsorbent, and the hydrophilic glycyrrhizin is separated and removed. Accordingly, the licorice extract adsorbed on the porous resin adsorbent is free or contains trace amounts of glycyrrhizin.
  • the porous resin adsorbent is a resin molded article containing a plurality of pores, which may be hydrophobic.
  • the porous resin adsorbent may be hydrophobic with a porous structure capable of adsorbing pharmacologically active active ingredients such as anti-cavity components without adsorbing glycyrrhizin.
  • the shape and size of the porous resin adsorbent are not limited.
  • Porous resin adsorbents may have, for example, the shape of bulks, pellets, or particles.
  • the porous resin adsorbent may have a size (diameter, width, length) of, for example, 50 ⁇ m to 5 cm in the form of pellets or particles.
  • the resin constituting the porous resin adsorbent is not limited as long as it is hydrophobic.
  • the porous resin adsorbent may be one obtained by molding a synthetic resin such as an aromatic or aliphatic system into a porous body.
  • the porous resin adsorbent may include, for example, one or more selected from styrene-divinylbenzene, methacrylate, and derivatives thereof.
  • the porous resin adsorbent introduces a substituent such as a sulfone group into the benzene ring of styrene-divinylbenzene as a polymer of styrene-divinylbenzene, a polymer of methacrylate, or a derivative of styrene-divinylbenzene.
  • a substituent such as a sulfone group into the benzene ring of styrene-divinylbenzene as a polymer of styrene-divinylbenzene, a polymer of methacrylate, or a derivative of styrene-divinylbenzene.
  • the porous resin adsorbent may use a commercially available product.
  • HP series HP10, HP20, HP30, HP40, etc.
  • SP series SP series
  • SP800, SP825, SP850, etc. HPMG series
  • HP1MG, HP2MG, etc. methacrylates.
  • HP20 may be usefully used as the HP series.
  • the dilution solvent is added to the extract according to the viscosity of the extract obtained through the second extraction, followed by dilution.
  • the dilution solvent may be used at least one selected from water and an organic solvent.
  • the organic solvent is as listed above, preferably an ethanol aqueous solution can be used.
  • the resin adsorbent increases the adsorption amount of the pharmacologically active active ingredient, and the hydrophilic glycyrrhizin is separated from the water of the step (a) and ( b)
  • the removal rate may be improved by dissolving and removing the solution in a low concentration organic solvent solution. That is, in the case of continuous contacting (adsorption) through the steps (a) and (b), the separation and removal are performed so that the content of glycyrizine is close to zero and preferably the content of glycyrrhizine is zero. can do.
  • the organic solvent solution of low concentration in the step (b) is an aqueous solution of 60% by weight or less. That is, the low concentration organic solvent aqueous solution is an aqueous solution of 60% by weight of ethanol based on the total aqueous solution. When the content of ethanol exceeds 60% by weight, the pharmacologically active active ingredient adsorbed on the resin adsorbent may be dissolved and separated.
  • the low concentration organic solvent aqueous solution is specifically 30 to 60% by weight of ethanol aqueous solution. Preferably, it is 50 weight% or less, More specifically, 30-50 weight% of ethanol aqueous solution is preferable.
  • the desorption step of separating the pharmacologically active ingredient adsorbed on the porous resin adsorbent from the porous resin adsorbent is performed. Specifically, after the adsorption step, the porous resin adsorbent is separated and removed so that the content of glycyrrhizine is close to zero (zero) or zero (zero), and the licorice extract containing a large amount of pharmacologically active active ingredients such as anti-cavities (hereinafter, ' Licorice extract 'is adsorbed, which is obtained by separating it from the porous resin adsorbent.
  • the desorption can be considered various methods if the licorice extract adsorbed on the porous resin adsorbent can be considered, for example, a dissolution method using a solvent can be selected.
  • the porous resin adsorbent on which the licorice extract is adsorbed may be contacted with a solvent to separate the licorice extract by dissolving it in the solvent.
  • a solvent preferably 70 to 98% by weight of an ethanol aqueous solution can be used. In this case, when the concentration of ethanol is less than 70% by weight, the solubility may be low, and the yield may be insignificant. When it exceeds 98% by weight, the ethanol aqueous solution may have high volatility, which may be undesirable.
  • a batch type may be sufficient and continuous flow type may be sufficient.
  • the porous resin adsorbent on which the licorice extract is adsorbed and a solvent are put together and stirred (dissolved) in a vessel provided with a stirrer.
  • a solvent preferably 70 to 98% by weight of an ethanol aqueous solution
  • it is a continuous flow using a column.
  • the porous resin adsorbent on which licorice extract is adsorbed is filled into the column, and then contacted (dissolved) by continuously passing a solvent (preferably 70 to 98% by weight of an ethanol aqueous solution) through the column. .
  • the process is more monotonous than a batch and can proceed continuously with the adsorption step.
  • the adsorption step is a continuous flow formula using the column in terms of process efficiency, in this case, if the desorption step also uses the column, it can proceed to the method of passing the solvent through the column immediately after the adsorption, adsorption and desorption Can proceed continuously.
  • the remaining glycyrrhizin in the licorice extract is secondarily removed. That is, primary separation is removed by hot water extraction, and secondary removal is performed by adsorptive separation through a porous resin adsorbent.
  • the licorice extract finally obtained as described above that is, the licorice extract obtained through the adsorption step and the desorption step
  • the content of glycyrizine is 1.0% by weight or less, specifically 0 (zero)% by weight To 1.0% by weight.
  • glycyrazine is effectively removed as zero weight percent.
  • Licorice extract, in which glycyrrhizin has been effectively removed can be used in anti-cavity compositions as described below.
  • the method for preparing licorice extract according to the present invention includes at least four steps described in the above-described glycidazine removal method. Specifically, the first extraction step of extracting hot water licorice;
  • a desorption step of separating the pharmacologically active active ingredient by dissolving it in contact with a solvent by contacting the porous resin adsorbent to which the pharmacologically active active ingredient is adsorbed Since each of these steps is as described above, a detailed description thereof will be omitted.
  • the method for preparing licorice extract according to the present invention is to be carried out after the three steps (the first extraction step, the second extraction step, the adsorption step and the desorption step), the licorice extract Concentrating may be further included.
  • the desorption step is carried out by a method of contacting (dissolving) a solvent
  • the licorice extract contains a solvent (ethanol aqueous solution), in which case it is heated to a temperature of 30 ⁇ 100 °C according to the use of licorice extract Concentrating step (concentration step) may further include.
  • the heating temperature at the time of concentration is less than 30 °C low volatility of the solvent may take a long time to concentrate, if it exceeds 100 °C may also be volatile pharmacologically active active ingredients such as anti-cavities components.
  • the concentration step is preferably carried out under reduced pressure, for example, it is preferably carried out under a pressure of 10 ⁇ 700 Torr within the temperature range. Concentration in this pressure range is advantageous in terms of concentration efficiency.
  • the heating time in the concentration step is not particularly limited, but may be 10 minutes to 8 hours within the temperature range. In this case, when the heating time is less than 10 minutes, the concentration efficiency is lowered, and when more than 8 hours, the synergistic effect according to the excess time is not so large and may be undesirable in terms of energy cost.
  • the extract concentrated through the concentration step as described above may be dried through natural drying, hot air drying or freeze drying, if necessary.
  • the dried extract may be commercialized in a powdered state or mixed in various formulation compositions, such as anti-cavity compositions.
  • the method for preparing licorice extract according to the present invention may further comprise adding an excipient to the concentrated extract.
  • the excipient imparts water solubility to the licorice extract, or acts as a viscosity regulator for concentration, it may be selected from water-soluble sugars or fatty acids.
  • Excipients can be used, for example, one or more selected from carrageenan, lactose, dextrin, cyclodextrin, casein, pectin, xanthan gum and pectin and the like. Such excipients may be added, for example, from 1 to 100 parts by weight based on 100 parts by weight of the concentrated extract.
  • the licorice extract to which the excipient is added as described above may be dried through natural drying, hot air drying or freeze drying, as needed.
  • the dried extract may be commercialized in a powdered state or mixed in various formulation compositions, such as anti-cavity compositions.
  • the licorice extract according to the present invention is a glycyrrhigin is removed, prepared according to the method for producing a licorice extract according to the present invention as described above, and contains no or very low content of glycyrrhizin.
  • the licorice extract according to the present invention is prepared by the same method as described above, and includes pharmacologically active ingredients such as anti-cavities as an active ingredient, but contains less than 1.0% by weight of glycidazine.
  • glycyrrhizin is effectively removed so that the content of glycyrrhizine is zero weight percent.
  • Licorice extract according to the present invention may be selected from, for example, liquid, paste, powder (solid) and the like. For example, after concentration as described above, it may have a powdery formulation through drying.
  • Licorice extract according to the present invention is effectively removed as described above glycerin, there is no side effect due to glycyrrhizin.
  • the licorice extract according to the present invention is in the presence of sugars, for example, in the presence of sugars such as glucose (glucose) or sucrose (sucrose) of caries-inducing bacteria such as Streptococcus mutans (S.mutans) bacteria It effectively suppresses growth.
  • the licorice extract according to the present invention can be usefully applied (included) as an anti-carcinoma active ingredient for inhibiting dental caries in foods such as confectionary, candy, candy, chocolate and gum containing a lot of sugar components. have.
  • the anti-cavities composition according to the present invention the licorice extract of the present invention.
  • the formulation of the anti-cavities composition in the present invention is not limited.
  • the anti-cavities composition according to the present invention, including the licorice extract of the present invention is not limited as long as it has anti-cavities performance (antibacterial), for example, it can be selected from pharmacological compositions, food compositions and oral compositions and the like. have.
  • the food composition may include sweets, candy, candy, chocolate, gum composition, and the like.
  • the oral composition may include, for example, a toothpaste composition and an oral cleaning composition.
  • the anti-cavities composition according to the present invention when the anti-cavities composition according to the present invention is a toothpaste composition, the anti-cavities composition according to the present invention comprises a toothpaste base component and the licorice extract of the present invention.
  • the toothpaste base component constitutes a conventional toothpaste composition, which may include, for example, an abrasive and a surfactant.
  • the total licorice extract may comprise 1.0 ppm to 10.0% by weight based on the total weight of the composition.
  • the effect such as anti-cavities according to the content of licorice extract may be insignificant, and if the content exceeds 10.0% by weight, the anti-cariogenic function difference according to the increase of the content of licorice extract is not large May affect the formulation of the drug.
  • the licorice extract is preferably included in 30 ⁇ 100ppm based on the total weight of the anti-cavities composition.
  • glycyrrhizin in licorice is effectively removed by adsorptive separation through a porous resin adsorbent. Accordingly, it is possible to provide a licorice extract having no side effects.
  • a licorice extract obtained through the column was obtained, and it was concentrated under reduced pressure for 8 hours at a temperature of 85 ° C. Thereafter, carrageenan (10 wt% total weight of the concentrated extract) was added to the concentrated licorice extract as an excipient and concentrated to obtain a paste extract. Next, lyophilized for 3 days at -50 °C, 15 Torr to prepare a licorice extract in powder form.
  • licorice was concentrated immediately after performing hot water extraction and ethanol extraction, without contacting the resin adsorbent (HP20). After concentration, an excipient (carrageenan) was added, and then lyophilized was used as a licorice extract specimen according to Comparative Example 2.
  • the content of glycyrrhizin was measured using HPLC (High-Pressure Liquid Chromatography), and the results are shown in the following [Table 1].
  • the content (% by weight) of the following [Table 1] is based on the total weight of licorice extract.
  • Figure 1 is a graph showing the results of the antimicrobial evaluation according to the concentration of licorice extract prepared according to the embodiment, the graph showing the MIC (Minimum Inhibitory Concentration) results as O.D (Optical Density) value.
  • the antimicrobial evaluation results were performed using the Streptococcus mutans (S.mutans), a decay-inducing bacterium, as the MIC (Minimum Inhibitory Concentration) test method recommended by the National Committee of Clinical Laboratory Standard (NCCLS) as follows. .
  • TLB Triptic Soy Broth
  • the licorice extract according to the present invention was confirmed to have antimicrobial activity against the Streptococcus mutans (S.mutans).
  • the antimicrobial (O.D value) was found to increase as the concentration of licorice extract increases.
  • the licorice extract according to the embodiment of the present invention was found to have excellent antimicrobial activity by inhibiting the activity of Streptococcus mutans (S.mutans) even at low concentrations of 30ppm and 40ppm .
  • the culture of bacteria (S.mutans) was carried out for 48 hours in 37 °C, 5wt% CO 2 environment.
  • the licorice extract was compared to the untreated specimens ('No saliva treatment' in the graph of Figure 2).
  • the licorice extract prepared according to the embodiment was found to have a growth inhibitory effect on the Streptococcus mutans (S.mutans) bacteria in the presence of glucose (glucose).
  • S.mutans Streptococcus mutans
  • glucose glucose
  • the licorice extract prepared according to the embodiment was found to have a growth inhibitory effect of Streptococcus mutans bacteria in the presence of sucrose. In case of coating, good results were obtained even at low concentrations, and in the case of adding, good results were obtained at concentrations of more than 50 ppm of licorice extract.
  • licorice extract prepared according to the present invention is effective in the growth of Streptococcus mutans (S.mutans) even in the presence of sugars such as glucose (glucose) or sucrose (sucrose) It can be seen that. Accordingly, it can be seen that it can be usefully applied to foods with a high content of sugar such as sweets, candy, chocolate, and the like.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a method for deglycyrrhizinating liquorice, to deglycyrrhizinated liquorice extracts and to a method for preparing same, and to an anti-caries composition.

Description

감초의 글리시리진 제거방법, 글리시리진이 제거된 감초 추출물 및 그 제조방법, 그리고 항충치 조성물Method of removing glycyrrhizine from licorice, licorice extract from glycyrrhizine, and preparation method thereof
본 발명은 감초의 글리시리진 제거방법, 글리시리진이 제거된 감초 추출물 및 그 제조방법, 그리고 항충치 조성물에 관한 것으로, 보다 상세하게는 감초를 열수 및 용매 추출한 후, 다공질의 레진 흡착제를 이용하여 잔존하는 글리시리진을 흡착 제거함으로써, 감초 중의 글리시리진을 효과적으로 제거할 수 있는 감초의 글리시리진 제거방법, 글리시리진이 제거된 감초 추출물 및 그 제조방법, 그리고 상기 글리시리진이 제거된 감초 추출물을 포함하는 항충치 조성물에 관한 것이다.The present invention relates to a method for removing glycyrrhizine of licorice, a licorice extract from which glycyrigin has been removed, and a method for preparing the same, and more particularly, to extracting licorice from hot water and solvent extraction, and then using the porous resin adsorbent. The present invention relates to a method for removing glycyrrhizine of licorice, which is capable of effectively removing glycyrizine in licorice, and to a method for preparing licorice extract from which glycyridin has been removed, and an anti-carbohydrate composition comprising the licorice extract from which glycisgin is removed.
식생활 형태가 다양해짐에 따라 당류의 소비가 증가되어 구강 내 미생물이 증가하고 있다. 충치는 구강 내 미생물 중, 특히 스트렙토코커스 뮤탄스( Streptococcus mutans) 균이 주요 원인이 되어 치아 중 무기질을 탈회시키고 상아질을 파괴시켜 치아조직의 결손을 초래하는 세균성 치아 질환으로서, 이는 성인 80% 이상이 갖고 있는 것으로 보고되고 있다. As dietary patterns are diversified, the consumption of sugars is increased, increasing the number of microorganisms in the oral cavity. Tooth decay is a bacterial dental disease that causes the decay of dental tissue by demineralizing the minerals in the teeth and destroying dentin by causing bacteria in the oral cavity, especially Streptococcus mutans. It is reported to have.
일반적으로, 충치(치아우식)는 치아, 뮤탄스(mutans) 균 및 탄수화물의 3가지 조건이 존재할 때 발생한다. 뮤탄스 균은 에너지원인 수크로즈(sucrose)를 분해하여 생육에 이용하고, 수크로즈를 기질로 해서 글루코스(glucose)와 프럭토스(fructose)를 생성한다. 그리고 생성된 글루코스는 미생물의 부착집단인 플라그(plaque)를 형성시키는 주된 원인으로 보고되고 있다. In general, tooth decay occurs when three conditions exist: teeth, mutans, and carbohydrates. Mutans bacteria decompose sucrose, an energy source, to be used for growth, and produce glucose and fructose using sucrose as a substrate. Glucose produced is reported to be a major cause of forming plaque, which is an attachment group of microorganisms.
현재, 식품관련 분야에서 항충치에 관한 연구가 진행되고 있으며, 천연물질로부터 항충치균(항우식균) 작용을 가진 물질의 분리와, 수크로즈를 대체하는 감미 성분에 관한 연구가 주류를 이루고 있다. 예를 들어, 녹차 및 우롱차에 함유된 카테친(catechin) 등이 항충치균에 대해 저해활성을 갖는 것으로 확인되었다. 또한, 감초 추출물의 경우에도 항충치균에 대한 강력한 저해활성을 갖는 것으로 보고되었다. Currently, research on anti-caries has been conducted in the food-related field, and the research on separation of substances having anti-cartococcus activity from natural substances and sweetening ingredients replacing sucrose has been mainstream. For example, catechins and the like contained in green tea and oolong tea have been found to have inhibitory activity against anti-detox bacteria. In addition, licorice extract has been reported to have a strong inhibitory activity against anti-detox bacteria.
예를 들어, 대한민국 등록특허 제10-0454226호는 충치균의 생육과 활성을 억제하는 감초 추출물의 제조방법 및 감초 추출물을 함유하는 기능성 항충치 물질이 제시되어 있다. For example, Korean Patent No. 10-0454226 discloses a method for preparing licorice extract that inhibits the growth and activity of cavities and a functional anti-cavity material containing licorice extract.
그러나 감초 추출물에는 충치균의 활성을 억제하는 성분과 함께 인체 부작용을 나타내는 글리시리진(glycyrrhizin)이 다량 함유되어 있다. 일반적으로, 글리시리진은 고혈압증, 부종, 저칼륨혈증, 저레닌혈증 등의 부작용을 갖는 것으로 알려져 있다. 이에 따라, 감초 추출물을 항충치 등을 위한 인체 적용물질로 사용하기 위해서는 글리시리진을 제거하여야 한다. 상기 선행특허에서는 열수 추출을 통하여 글리시리진을 제거하고 있다. 그러나 이러한 방법만으로는 감초 중의 글리시리진을 효과적으로 제거할 수 없다.However, licorice extract contains a large amount of glycyrrhizin (glycyrrhizin), which exhibits side effects in the human body, along with components that inhibit the activity of caries. In general, glycyrazine is known to have side effects such as hypertension, edema, hypokalemia, hyporeninemia and the like. Accordingly, in order to use licorice extract as a human application material for anti-cavities, glycyrrhizin should be removed. In the above patent, glycyrrhigin is removed by hydrothermal extraction. However, these methods alone cannot effectively remove glycyrrhizin in licorice.
이에, 본 발명은 감초 중의 글리시리진을 효과적으로 제거할 수 있는 감초의 글리시리진 제거방법을 제공하는 데에 그 목적이 있다. Accordingly, an object of the present invention is to provide a method for removing glycyrrhizine of licorice which can effectively remove glycyrrhizine in licorice.
또한, 본 발명은 글리시리진이 효과적으로 제거되어 글리시리진에 의한 부작용이 없는 우수한 항균성(항충치 성능)을 가지는 감초 추출물 및 그 제조방법, 그리고 상기 글리시리진이 제거된 감초 추출물을 포함하는 항충치 조성물을 제공하는 데에 목적이 있다.In another aspect, the present invention provides an anti-carbohydrate composition comprising a licorice extract having an excellent antimicrobial activity (anti-cariogenic performance) without the side effect caused by glycyrrhizin effectively removed, and a method for preparing the same There is a purpose.
상기 목적을 달성하기 위하여 본 발명은, The present invention to achieve the above object,
감초를 열수 추출하는 제1차 추출단계; A first extraction step of extracting hot water from licorice;
상기 제1차 추출된 감초를 여과한 후, 감초 잔사에 유기 용매를 가하여 추출하는 제2차 추출단계; Filtering the first extracted licorice, and then extracting the organic liquor by adding an organic solvent to the licorice residue;
상기 제2차 추출하여 얻어진 감초 추출물을 다공질의 레진 흡착제와 접촉시키는 흡착단계; 및 An adsorption step of contacting the licorice extract obtained by the second extraction with a porous resin adsorbent; And
상기 다공질의 레진 흡착제에 흡착된 감초 추출물을 다공질의 레진 흡착제로부터 분리시키는 탈착단계를 포함하는 감초의 글리시리진 제거방법을 제공한다. Provided is a method for removing glycyrrhizine of licorice comprising a desorption step of separating the licorice extract adsorbed on the porous resin adsorbent from the porous resin adsorbent.
또한, 본 발명은, In addition, the present invention,
감초를 열수 추출하는 제1차 추출단계; A first extraction step of extracting hot water from licorice;
상기 제1차 추출된 감초를 여과한 후, 감초 잔사에 유기 용매를 가하여 추출하는 제2차 추출단계; Filtering the first extracted licorice, and then extracting the organic liquor by adding an organic solvent to the licorice residue;
상기 제2차 추출하여 얻어진 감초 추출물을 다공질의 레진 흡착제와 접촉시키는 흡착단계; 및 An adsorption step of contacting the licorice extract obtained by the second extraction with a porous resin adsorbent; And
상기 다공질의 레진 흡착제에 흡착된 감초 추출물을 다공질의 레진 흡착제로부터 분리시키는 탈착단계를 포함하는 감초 추출물의 제조방법을 제공한다. It provides a licorice extract comprising a desorption step of separating the licorice extract adsorbed on the porous resin adsorbent from the porous resin adsorbent.
이때, 상기 흡착단계는, 상기 제2차 추출하여 얻어진 감초 추출물에 희석 용매를 가하여 희석시킨 다음, 다공질의 레진 흡착제와 접촉시키는 것이 좋다. At this time, in the adsorption step, the dilution solvent is added to the licorice extract obtained by the second extraction and diluted, and then contacted with a porous resin adsorbent.
바람직한 구현예에 따라서 상기 흡착단계는, (a) 상기 제2차 추출하여 얻어진 감초 추출물에 물을 가하여 희석시킨 다음, 다공질의 레진 흡착제와 제1차 접촉시키는 공정; 및 (b) 상기 제1차 접촉된 감초 추출물에 30 ~ 60중량%의 에탄올 수용액을 가하여 희석시킨 다음, 다공질의 레진 흡착제와 제2차 접촉시키는 공정을 포함하는 것이 좋다. According to a preferred embodiment, the adsorption step includes the steps of: (a) diluting the licorice extract obtained by the second extraction with water, followed by primary contact with a porous resin adsorbent; And (b) adding 30 to 60% by weight of an ethanol aqueous solution to the first contacted licorice extract, followed by dilution, followed by a second contact with a porous resin adsorbent.
또한, 상기 탈착단계는 희석 용매, 바람직하게는 70 ~ 98중량%의 에탄올 수용액을 이용하여 다공질의 레진 흡착제로부터 감초 추출물을 분리시키는 것이 바람직하다. In addition, in the desorption step, licorice extract is preferably separated from the porous resin adsorbent using a dilute solvent, preferably 70 to 98% by weight of an ethanol aqueous solution.
이에 더하여, 본 발명은, 상기 제조방법에 따라 제조되고, 글리시리진의 함량이 1.0중량% 이하인 감초 추출물을 제공한다. In addition, the present invention provides a licorice extract, which is prepared according to the preparation method and whose content of glycyrrhizine is 1.0 wt% or less.
아울러, 본 발명은 상기 감초 추출물을 포함하는 항충치 조성물을 제공한다.In addition, the present invention provides an anti-cavities composition comprising the licorice extract.
본 발명에 따르면, 감초를 열수 및 유기 용매 추출한 후, 다공질의 레진 흡착제를 통한 흡착, 분리에 의해 글리시리진이 효과적으로 제거된 감초추출물을 얻을 수 있게 되며, 이를 항충치 조성물에 사용하면 글리시리진에 의한 부작용이 없어 안심하고 사용할 수 있는 항충치 조성물을 얻을 수 있게 된다.According to the present invention, after licorice is extracted with hot water and an organic solvent, a licorice extract from which glycyrizine is effectively removed by adsorption and separation through a porous resin adsorbent can be obtained. It is possible to obtain an anti-cavity composition that can be used without any worry.
도 1은 본 발명의 실시예에 따라 제조된 감초 추출물의 항균 평가 결과를 보인 그래프이다. 1 is a graph showing the results of the antimicrobial evaluation of licorice extract prepared according to an embodiment of the present invention.
도 2는 본 발명의 실시예에 따라 제조된 감초 추출물의 글루코스(glucose) 존재 하에서 스트렙토코커스 뮤탄스(S.mutans) 균의 생육 억제 평가 결과를 보인 그래프이다. Figure 2 is a graph showing the growth inhibition evaluation results of Streptococcus mutans (S.mutans) bacteria in the presence of glucose (glucose) of the licorice extract prepared according to an embodiment of the present invention.
도 3은 본 발명의 실시예에 따라 제조된 감초 추출물의 수크로즈(sucrose) 존재 하에서 스트렙토코커스 뮤탄스(S.mutans) 균의 생육 억제 평가 결과를 보인 그래프이다.Figure 3 is a graph showing the results of growth inhibition evaluation of Streptococcus mutans (S.mutans) in the presence of sucrose (sucrose) of the licorice extract prepared according to an embodiment of the present invention.
이하, 본 발명을 상세히 설명한다. Hereinafter, the present invention will be described in detail.
먼저, 본 발명에 따른 감초의 글리시리진 제거방법은, 감초를 열수 추출하는 제1차 추출단계; 상기 제1차 추출하여 얻어진 감초와 추출액의 혼합물을 여과하여 감초를 분리하고 분리된 감초에 유기 용매를 가한 다음 가열하여 추출하는 제2차 추출단계; 상기 제2차 추출하여 얻어진 감초와 추출액의 혼합물을 여과하여 추출액을 분리한 후, 분리된 추출액을 소수성인 다공질의 레진 흡착제와 접촉시켜 약리 활성 유효성분을 흡착하는 흡착단계; 및 상기 약리 활성 유효성분이 흡착된 다공질의 레진 흡착제를 용매와 접촉시켜 약리 활성 유효성분이 용매에 용해되도록 하여 분리시키는 탈착단계;를 포함한다. 본 발명의 제거방법에 따르면, 최종적으로 수득된 약리 활성 유효성분인 감초 추출물에 글리시리진의 함량이 1중량% 이하, 바람직하게는 0(zero)중량%로서 글리시리진이 효과적으로 제거된다. 각 단계별로 구체적으로 설명하면 다음과 같다. First, the glycyrrhizin removal method of licorice according to the present invention includes a first extraction step of extracting hot water from licorice; A second extraction step of filtering the mixture of licorice and extract obtained by the first extraction to separate licorice, adding an organic solvent to the separated licorice, and then heating and extracting it; An adsorption step of filtering the mixture of licorice and extract obtained by the second extraction to separate the extract and then adsorbing the separated extract with a hydrophobic porous resin adsorbent to adsorb pharmacologically active ingredients; And a desorption step of contacting the porous resin adsorbent, to which the pharmacologically active active ingredient is adsorbed, with a solvent so as to dissolve the pharmacologically active active ingredient in a solvent. According to the removal method of the present invention, glycyrrhizine is effectively removed from the licorice extract, which is the finally obtained pharmacologically active ingredient, in an amount of 1% by weight or less, preferably 0% by weight. The detailed description of each step is as follows.
제1차 추출단계(열수 추출)First Extraction Step (Hot Water Extraction)
본 발명에서 추출 대상이 되는 감초는, 바람직하게는 감초의 뿌리이다. 이때, 감초의 뿌리는 건조된 것이 좋으며, 예를 들어 0.2 ~ 5cm의 크기로 쇄절된 것이나, 50㎛ ~ 1mm의 크기로 분쇄된 것을 사용할 수 있다. Licorice to be extracted in the present invention is preferably the root of licorice. At this time, the root of licorice is good to be dried, for example, it is crushed to the size of 0.2 ~ 5cm, it can be used to crushed to the size of 50㎛ ~ 1mm.
먼저, 위와 같은 감초(뿌리)를 열수 추출한다. 이러한 열수 추출을 통해 이물질과 함께 글리시리진이 1차적으로 제거된다. 특별히 한정하는 것은 아니지만, 감초에 감초 무게의 10 ~ 30배의 물을 혼합한 다음, 40 ~ 150℃의 온도 가열하여 열수 추출하는 것이 바람직하다. 이때, 열수 추출 온도가 40℃ 미만이면 글리시리진의 용출성이 미미할 수 있고, 150℃를 초과하면 항충치 성분 등의 약리 활성 유효성분이 추출될 수 있다. 이러한 점을 고려할 때, 열수 추출 온도는 60 ~ 120℃가 보다 바람직하다. First, hot water is extracted from the above licorice (root). This hydrothermal extraction primarily removes glycyrazine along with foreign matter. Although it does not specifically limit, It is preferable to mix 10 to 30 times the weight of licorice with licorice, and to heat-extract hot water at 40-150 degreeC. At this time, when the hot water extraction temperature is less than 40 ° C, the elubility of glycyrrhizine may be insignificant, and when it exceeds 150 ° C, pharmacologically active active ingredients such as anti-cavities components may be extracted. In view of this point, the hot water extraction temperature is more preferably 60 to 120 ° C.
또한, 상기 열수 추출은, 예를 들어 10분 ~ 3시간동안 진행될 수 있다. 열수 추출 시간이 10분미만으로 너무 짧으면 글리시리진의 용출성이 미미할 수 있고, 3시간을 초과하여 너무 긴 경우 과잉 시간에 따른 상승효과가 그다지 크지 않고 에너지 비용 면에서 바람직하지 않을 수 있다. In addition, the hot water extraction may be performed, for example, for 10 minutes to 3 hours. If the hydrothermal extraction time is too short, less than 10 minutes, the solubility of glycyrizine may be insignificant, and if it is too long for more than 3 hours, the synergistic effect of the excess time may not be so great and undesirable in terms of energy cost.
아울러, 열수 추출은 1회 이상이다. 바람직하게는, 상기 온도 범위와 시간 범위 이내에서 진행하되, 상압 하에서 3회 이상 반복 추출하는 것이 글리시리진의 제거효율 면에서 좋다. 구체적인 예를 들어, 상압에서 3회 ~ 5회 반복 추출하는 것이 좋다. 또한, 열수 추출은, 예를 들어 감초 뿌리를 망상구조의 통에 담아 물이 수용된 용기에 침수시켜 추출할 수 있다. In addition, hot water extraction is one or more times. Preferably, while proceeding within the temperature range and time range, the extraction is repeated three or more times under normal pressure in terms of the removal efficiency of glycyrazine. For example, it is good to extract 3 to 5 times at normal pressure. In addition, hot water extraction can be extracted by immersing licorice root in the container of a network structure, for example, immersing in the container containing water.
위와 같은 열수 추출(제1차 추출)을 통해 감초(뿌리) 중에 함유된 글리시리진이 1차적으로 제거된다. Through the above hydrothermal extraction (primary extraction), glycyrrhizin contained in the licorice (root) is primarily removed.
제2차 추출단계(유기 용매 추출)Second extraction step (organic solvent extraction)
상기 제1차 추출하여 얻어진 감초와 추출액의 혼합물에서 감초를 여과 분리한 후, 분리된 감초에 유기 용매를 가한 다음, 상기 감초와 유기 용매의 혼합물을 가열하여 용매 추출한다. 즉, 열수 추출한 후, 감초와 추출액(글리시리진이 포함된 여액)을 여과지 등을 통해 여과하여 감초만을 여과 분리하고, 분리된 감초에 유기 용매를 혼합한 다음, 재차 추출하는 것이다. 이때, 상기 추출액에 포함된 글리시리진은 정제 공정을 통해 회수될 수 있다. After licorice is separated by filtration from the mixture of licorice and extract obtained by the first extraction, an organic solvent is added to the separated licorice, and then the mixture of the licorice and the organic solvent is heated to solvent extraction. That is, after hot water extraction, licorice and the extract (filtrate containing glycyrrhizine) are filtered through filter paper or the like, and the licorice is separated by filtration. The organic liquor is mixed with the separated licorice and then extracted again. At this time, glycyrrhizin contained in the extract may be recovered through a purification process.
상기 유기 용매는 제한되지 않는다. 유기 용매는, 예를 들어 에탄올, 메탄올, 부탄올, 프로판올, 에틸아세테이트, 아세톤, 클로로포름 및 핵산올 등으로부터 선택된 하나 이상을 포함할 수 있으며, 바람직하게는 에탄올을 포함하는 것이 좋다. 유기 용매는, 구체적인 예를 들어 30 ~ 98중량%의 에탄올 수용액을 사용할 수 있다. The organic solvent is not limited. The organic solvent may include one or more selected from, for example, ethanol, methanol, butanol, propanol, ethyl acetate, acetone, chloroform, nucleic acid and the like, and preferably includes ethanol. As an organic solvent, 30-98 weight% of ethanol aqueous solution can be used specifically ,.
이때 특별히 한정하는 것은 아니지만, 감초 무게의 5 ~ 30배의 유기 용매(예, 에탄올 등)를 혼합한 다음, 30 ~ 100℃의 온도로 가열하여 용매 추출하는 것이 바람직하다. 이러한 유기 용매를 이용한 용매 추출(제2차 추출)에 의해, 항충치 성분 등의 약리 활성 유효성분이 포함된 추출액이 추출된다. 이때, 유기 용매를 감초 무게 대비 5배 미만으로 사용한 경우, 충분한 추출이 이루어지지 않을 수 있다. 그리고 유기 용매의 사용량이 30배를 초과한 경우, 과잉 용매 사용에 따른 상승효과가 그다지 크지 않고, 추후 농축 시간이 오래 걸릴 수 있다. 또한, 추출 온도가 30℃ 미만이면 유효성분(항충치 성분 등)의 용출성이 미미할 수 있고, 100℃를 초과하면 유기 용매의 휘발성이 높아질 수 있다. 이러한 점을 고려할 때, 유기 용매를 감초 무게의 10 ~ 20배로 가하여 50 ~ 90℃의 온도에서 추출하는 것이 보다 바람직하다. Although not specifically limited at this time, it is preferable to mix 5-30 times the organic solvent (for example, ethanol) of licorice weight, and to heat-extract the solvent at 30-100 degreeC. By solvent extraction (secondary extraction) using such an organic solvent, an extract containing pharmacologically active active ingredients such as anti-cavities components is extracted. At this time, when the organic solvent is used less than 5 times the weight of licorice, sufficient extraction may not be made. When the amount of the organic solvent used is more than 30 times, the synergistic effect of using the excess solvent is not very large, and the concentration time may be long. In addition, when the extraction temperature is less than 30 ° C, the dissolution properties of the active ingredient (anti-cause components, etc.) may be insignificant, and when the extraction temperature exceeds 100 ° C, the volatility of the organic solvent may increase. In view of this point, it is more preferable to add an organic solvent at 10-20 times the weight of licorice and extract it at a temperature of 50-90 ° C.
또한, 상기 용매 추출 시간은, 예를 들어 10분 ~ 4시간이 좋다. 추출 시간이 10분 미만으로 너무 짧으면 유효성분의 용출성이 미미할 수 있고, 4시간을 초과하여 너무 긴 경우 과잉 시간에 따른 상승효과가 그다지 크지 않고 에너지 비용 면에서 바람직하지 않을 수 있다. 아울러, 위와 같은 용매 추출은 감압 하에서 1회 이상 진행하는 것이 좋다. 바람직하게는, 상기 온도 범위와 시간 범위 이내에서 진행하되, 10 ~ 700Torr의 압력 하에서 1회 이상 추출하는 것이 좋다. In addition, the said solvent extraction time is 10 minutes-4 hours, for example. If the extraction time is too short, less than 10 minutes, the elutability of the active ingredient may be insignificant, and if the extraction time is too long over 4 hours, the synergistic effect of the excess time is not so large and may be undesirable in terms of energy costs. In addition, the solvent extraction is preferably performed at least once under reduced pressure. Preferably, while proceeding within the temperature range and time range, it is good to extract at least once under a pressure of 10 ~ 700 Torr.
위와 같은 유기 용매를 이용한 용매 추출(제2차 추출)을 통해, 감초 중에 함유된 항충치 성분 등의 약리 활성 유효성분이 추출된 추출액이 얻어진다. 이와 같이 얻어진 추출액은 아래에서 설명하는 흡착단계를 거친다. 즉, 상기와 같이 용매 추출(제2차 추출)한 후, 여과지 등을 통해 감초(감초 박)와 추출액을 분리한 다음, 분리된 추출액을 아래의 흡착단계를 거치게 한다. 이때, 상기 얻어진 추출액은 경우에 따라 농축되거나 희석된 후에 아래의 흡착단계를 거칠 수 있다. Through solvent extraction (secondary extraction) using the organic solvent as described above, an extract obtained by extracting pharmacologically active active ingredients such as anti-cavities components contained in licorice is obtained. The extract thus obtained is subjected to the adsorption step described below. That is, after the solvent extraction (secondary extraction) as described above, licorice (licorice foil) and the extract liquid is separated through a filter paper, etc., the separated extract is subjected to the adsorption step below. At this time, the obtained extract may be subjected to the following adsorption step after being concentrated or diluted in some cases.
흡착단계Adsorption step
상기 2차 추출을 통해 얻어진 추출액을 다공질의 레진 흡착제와 접촉시킨다. 상기 추출약과 다공질의 레진 흡착제를 접촉시킴에 있어서는 배치식이어도 좋고, 연속 흐름식이어도 좋다. 예를 들어, 교반기가 설치된 용기에 상기 추출액과 다공질의 레진 흡착제를 함께 넣고 교반하는 배치식 방법으로 접촉시킬 수 있다. 이때, 다공질의 레진 흡착제는 추출액 무게의 예를 들어 10 ~ 100배로 가하여 접촉시킬 수 있다. 바람직하게는 컬럼(column)을 이용한 연속 흐름식으로서, 다공질의 레진 흡착제를 컬럼에 충전(packing)시킨 다음, 추출액을 상기 다공질의 레진 흡착제가 충전된 컬럼에 연속적으로 통과시키는 방법으로 접촉(흡착)시키는 것이 좋다. 이와 같이, 컬럼을 이용한 연속 흐름식의 경우, 배치식보다 짧은 시간 내에 다량의 추출액을 연속적으로 접촉시킬 수 있어 효율이 좋다. The extract obtained through the secondary extraction is contacted with a porous resin adsorbent. In contacting the extractant with the porous resin adsorbent, a batch type or a continuous flow type may be used. For example, the extract and the porous resin adsorbent may be put together in a vessel provided with a stirrer and contacted by a batch method. At this time, the porous resin adsorbent can be contacted by adding, for example, 10 to 100 times the weight of the extract. Preferably, as a continuous flow using a column, the porous resin adsorbent is packed into the column, and then the extract is contacted (adsorption) by continuously passing the extract through the column filled with the porous resin adsorbent. It is good to let. As described above, in the case of the continuous flow type using the column, a large amount of the extract liquid can be continuously contacted within a shorter time than the batch type, so the efficiency is good.
위와 같이 다공질의 레진 흡착제와의 접촉을 통해 글리시리진이 2차적으로 분리 제거되어, 글리시리진이 효과적으로 제거된 약리 활성 유효성분인 감초 추출물이 이 얻어진다. 즉, 상기 용매 추출(2차 추출)을 통해 얻어진 추출액에는 항충치 성분 등의 약리 활성 유효성분과 함께 소량의 글리시리진이 포함되어 있는데, 이때 추출액에 포함된 항충치 성분 등의 약리 활성 유효성분은 다공질의 레진 흡착제에 흡착되고, 추출액에 잔존하는 글리시리진은 분리 제거된다. 구체적으로, 상기 다공질의 레진 흡착제는 소수성 물질을 선택적으로 흡착시킬 수 있는 것이 사용되는데, 소수성의 약리 활성 유효성분은 다공질의 레진 흡착제에 흡착되고, 친수성의 글리시리진은 분리되어 제거된다. 이에 따라, 다공질의 레진 흡착제에 흡착된 감초 추출물 중에는 글리시리진이 없거나 극미량이다. By contacting with the porous resin adsorbent as described above, glycyrrhizin is secondarily separated and removed, thereby obtaining a licorice extract which is a pharmacologically active ingredient in which glycyrrhizin is effectively removed. That is, the extract obtained through the solvent extraction (secondary extraction) contains a small amount of glycyrrhizin together with the pharmacologically active active ingredients such as anti-cavities components, wherein the pharmacologically active active ingredients such as the anti-cavities components included in the extract are porous The glycyrrhizine adsorbed by the resin adsorbent and remaining in the extract is separated and removed. Specifically, the porous resin adsorbent may be used to selectively adsorb a hydrophobic material. The hydrophobic pharmacologically active active ingredient is adsorbed onto the porous resin adsorbent, and the hydrophilic glycyrrhizin is separated and removed. Accordingly, the licorice extract adsorbed on the porous resin adsorbent is free or contains trace amounts of glycyrrhizin.
본 발명에서, 상기 다공질의 레진 흡착제는 다수의 기공(pore)을 포함하는 수지 성형체로서, 이는 소수성이면 좋다. 구체적으로, 다공질의 레진 흡착제는 글리시리진을 흡착시키지 않고, 항충치 성분 등의 약리 활성 유효성분을 흡착시킬 수 있는 다공성 구조의 소수성이면 좋다. 또한, 상기 다공질의 레진 흡착제의 형상이나 크기는 제한되지 않는다. 다공질의 레진 흡착제는, 예를 들어 벌크(bulk), 펠렛(pellet) 또는 입자 등의 형상을 가질 수 있다. 또한, 다공질의 레진 흡착제는, 펠렛(pellet)이나 입자 형상인 경우, 예를 들어 50㎛ 내지 5cm의 크기(직경, 가로, 세로)를 가질 수 있다. In the present invention, the porous resin adsorbent is a resin molded article containing a plurality of pores, which may be hydrophobic. Specifically, the porous resin adsorbent may be hydrophobic with a porous structure capable of adsorbing pharmacologically active active ingredients such as anti-cavity components without adsorbing glycyrrhizin. In addition, the shape and size of the porous resin adsorbent are not limited. Porous resin adsorbents may have, for example, the shape of bulks, pellets, or particles. In addition, the porous resin adsorbent may have a size (diameter, width, length) of, for example, 50 μm to 5 cm in the form of pellets or particles.
상기 다공질의 레진 흡착제를 구성하는 레진(resin)은 소수성이면 제한되지 않는다. 다공질의 레진 흡착제는 방향족계나 지방족계 등의 합성수지를 다공질체로 성형한 것을 사용할 수 있다. 다공질의 레진 흡착제는, 예를 들어 스티렌-디비닐벤젠(Styrene-Divinylbenzene), 메타크릴레이트(Methacrylate) 및 이들의 유도체 중에서 선택된 하나 이상을 포함할 수 있다. 구체적인 예를 들어, 상기 다공질의 레진 흡착제는 스티렌-디비닐벤젠의 중합체, 메타크릴레이트의 중합체, 또는 스티렌-디비닐벤젠의 유도체로서 스티렌-디비닐벤젠의 벤젠 고리에 술폰기 등의 치환기가 도입된 중합체로부터 성형된 것으로서, 다수의 기공(pore)을 포함하여 400 ~ 1,000㎡/g의 비표면적을 가지는 것을 사용할 수 있다. 아울러, 상기 다공질의 레진 흡착제는 상업적으로 판매되는 제품을 사용할 수 있다. 예를 들어 스티렌-디비닐벤젠계로서 HP 시리즈(HP10, HP20, HP30, HP40 등)나 SP 시리즈(SP800, SP825, SP850 등), 그리고 메타크릴레이트계로서 HPMG 시리즈(HP1MG, HP2MG 등) 제품 등을 사용할 수 있으며, 바람직하게는 HP 시리즈로서 HP20을 유용하게 사용할 수 있다. The resin constituting the porous resin adsorbent is not limited as long as it is hydrophobic. The porous resin adsorbent may be one obtained by molding a synthetic resin such as an aromatic or aliphatic system into a porous body. The porous resin adsorbent may include, for example, one or more selected from styrene-divinylbenzene, methacrylate, and derivatives thereof. For example, the porous resin adsorbent introduces a substituent such as a sulfone group into the benzene ring of styrene-divinylbenzene as a polymer of styrene-divinylbenzene, a polymer of methacrylate, or a derivative of styrene-divinylbenzene. As molded from the polymers, it is possible to use those having a specific surface area of 400 to 1,000 m 2 / g including a plurality of pores. In addition, the porous resin adsorbent may use a commercially available product. For example, HP series (HP10, HP20, HP30, HP40, etc.) or SP series (SP800, SP825, SP850, etc.) as styrene-divinylbenzene, and HPMG series (HP1MG, HP2MG, etc.) as methacrylates. May be used, and preferably HP20 may be usefully used as the HP series.
또한, 상기 제2차 추출을 통해 얻어진 추출액을 위와 같은 다공질의 레진 흡착제에 접촉(흡착)시킴에 있어서, 제2차 추출을 통해 얻어진 추출액의 점도에 따라 추출액에 희석 용매를 가하여 희석시킨 다음, 다공질의 레진 흡착제와 접촉시킬 수 있다. 이때, 상기 희석 용매는 물 및 유기 용매 중에서 선택된 하나 이상을 사용할 수 있다. 그리고 유기 용매는 상기 나열한 바와 같으며, 바람직하게는 에탄올 수용액을 사용할 수 있다. In addition, in contacting (adsorbing) the extract obtained through the second extraction with the porous resin adsorbent as described above, the dilution solvent is added to the extract according to the viscosity of the extract obtained through the second extraction, followed by dilution. Can be contacted with a resin adsorbent. In this case, the dilution solvent may be used at least one selected from water and an organic solvent. And the organic solvent is as listed above, preferably an ethanol aqueous solution can be used.
상기 제2차 추출을 통해 얻어진 추출액과 다공질의 레진 흡착제를 접촉(흡착)시킴에 있어서는, (a) 상기 제2차 추출하여 얻어진 감초 추출액에 물을 가하여 희석시킨 다음, 다공질의 레진 흡착제와 제1차 접촉시키는 공정; 및 (b) 상기 제1차 접촉된 감초 추출액에 저농도의 유기 용매 수용액을 가하여 희석시킨 다음, 다공질의 레진 흡착제와 제2차 접촉시키는 공정을 포함하는 것이 바람직하다. In contacting (adsorption) of the extract obtained through the second extraction and the porous resin adsorbent, (a) dilution by adding water to the licorice extract obtained by the second extraction, followed by the porous resin adsorbent and the first Secondary contacting process; And (b) diluting the first contacted licorice extract by diluting with a low concentration of an organic solvent, followed by a second contact with a porous resin adsorbent.
위와 같이, (a)공정 및 (b)공정의 2차에 걸친 접촉을 연속적으로 진행하는 경우, 레진 흡착제에는 약리 활성 유효성분의 흡착량이 많아지고, 친수성의 글리시리진은 (a)공정의 물과 (b)공정의 저농도 유기 용매 수용액에 용해 제거되어 제거율이 향상될 수 있다. 즉, 상기(a)공정 및 (b)공정을 통해 연속적으로 접촉(흡착)시키는 경우, 글리시리진의 함량이 0(zero)에 가깝도록, 바람직하게는 글리시리진의 함량이 0(zero)이 되도록 분리 제거할 수 있다. As described above, in the case where the second contact of the step (a) and the step (b) is performed continuously, the resin adsorbent increases the adsorption amount of the pharmacologically active active ingredient, and the hydrophilic glycyrrhizin is separated from the water of the step (a) and ( b) The removal rate may be improved by dissolving and removing the solution in a low concentration organic solvent solution. That is, in the case of continuous contacting (adsorption) through the steps (a) and (b), the separation and removal are performed so that the content of glycyrizine is close to zero and preferably the content of glycyrrhizine is zero. can do.
이때, 상기 (b)공정에서 저농도의 유기 용매 수용액은 60중량% 이하의 수용액이다. 즉, 상기 저농도의 유기 용매 수용액은, 수용액 전체 기준으로 에탄올의 함량이 60중량%인 수용액이다. 에탄올의 함량이 60중량%를 초과하는 경우, 레진 흡착제에 흡착된 약리 활성 유효성분이 용해 분리될 수 있다. 상기 저농도의 유기 용매 수용액은 구체적으로 30 ~ 60중량%의 에탄올 수용액이다. 바람직하게는, 50중량% 이하이며, 보다 구체적으로는 30 ~ 50중량%의 에탄올 수용액이 좋다. At this time, the organic solvent solution of low concentration in the step (b) is an aqueous solution of 60% by weight or less. That is, the low concentration organic solvent aqueous solution is an aqueous solution of 60% by weight of ethanol based on the total aqueous solution. When the content of ethanol exceeds 60% by weight, the pharmacologically active active ingredient adsorbed on the resin adsorbent may be dissolved and separated. The low concentration organic solvent aqueous solution is specifically 30 to 60% by weight of ethanol aqueous solution. Preferably, it is 50 weight% or less, More specifically, 30-50 weight% of ethanol aqueous solution is preferable.
탈착단계Desorption Step
위와 같이 흡착단계를 진행한 다음에는 상기 다공질의 레진 흡착제에 흡착된 약리활성 유효성분을 다공질의 레진 흡착제로부터 분리시키는 탈착단계를 진행한다. 구체적으로, 흡착단계 후, 다공질의 레진 흡착제에는 글리시리진의 함량은 0(zero) 또는 0(zero)에 가깝도록 분리 제거되고, 항충치 성분 등의 약리 활성 유효성분이 다량으로 함유된 감초 추출물(이하 '감초 추출물' 이라 한다.)이 흡착되어 있는데, 이를 다공질의 레진 흡착제로부터 분리 수득한다. After the adsorption step is carried out as described above, the desorption step of separating the pharmacologically active ingredient adsorbed on the porous resin adsorbent from the porous resin adsorbent is performed. Specifically, after the adsorption step, the porous resin adsorbent is separated and removed so that the content of glycyrrhizine is close to zero (zero) or zero (zero), and the licorice extract containing a large amount of pharmacologically active active ingredients such as anti-cavities (hereinafter, ' Licorice extract 'is adsorbed, which is obtained by separating it from the porous resin adsorbent.
본 발명에서 탈착은 다공질의 레진 흡착제에 흡착된 상기 감초 추출물을 분리할 수 있으면 다양한 방법이 고려될 수 있으며, 예를 들어 용매를 이용한 용해 방법이 선택될 수 있다. 구체적으로, 감초 추출물이 흡착된 다공질의 레진 흡착제를 용매와 접촉시켜, 감초 추출물이 용매에 용해되도록 하여 분리할 수 있다. 상기 용매는, 바람직하게는 70 ~ 98중량%의 에탄올 수용액을 사용할 수 있다. 이때, 에탄올의 농도가 70중량% 미만인 경우 용해도가 낮아 수득율이 미미할 수 있으며, 98중량%를 초과하는 경우 에탄올 수용액의 휘발성이 높아 바람직하지 않을 수 있다. In the present invention, the desorption can be considered various methods if the licorice extract adsorbed on the porous resin adsorbent can be considered, for example, a dissolution method using a solvent can be selected. Specifically, the porous resin adsorbent on which the licorice extract is adsorbed may be contacted with a solvent to separate the licorice extract by dissolving it in the solvent. As the solvent, preferably 70 to 98% by weight of an ethanol aqueous solution can be used. In this case, when the concentration of ethanol is less than 70% by weight, the solubility may be low, and the yield may be insignificant. When it exceeds 98% by weight, the ethanol aqueous solution may have high volatility, which may be undesirable.
또한, 위와 같이 용매를 통한 탈착을 진행함에 있어서는 배치식이어도 좋고, 연속 흐름식이어도 좋다. 구체적으로, 교반기가 설치된 용기에 감초 추출물이 흡착된 다공질의 레진 흡착제와 용매(바람직하게는, 70 ~ 98중량%의 에탄올 수용액)를 함께 넣고 교반하는 배치식 방법으로 접촉(용해)시킬 수 있다. 바람직하게는 컬럼을 이용한 연속 흐름식이다. 구체적으로, 감초 추출물이 흡착된 다공질의 레진 흡착제를 컬럼에 충전시킨 다음, 용매(바람직하게는, 70 ~ 98중량%의 에탄올 수용액)를 컬럼에 연속적으로 통과시키는 방법으로 접촉(용해)시키는 것이 좋다. 컬럼을 이용한 연속 흐름식의 경우, 배치식보다 공정이 단조롭고 흡착단계와 연속적으로 진행할 수 있다. 전술한 바와 같이, 상기 흡착단계는 컬럼을 이용한 연속 흐름식이 공정 효율 면에서 좋은데, 이때 탈착단계도 컬럼을 이용하는 경우, 흡착 후 곧바로 후속하여 컬럼에 용매를 통과시키는 방법으로 진행할 수 있어, 흡착과 탈착을 연속적으로 진행할 수 있다. In addition, in advancing desorption through a solvent as mentioned above, a batch type may be sufficient and continuous flow type may be sufficient. Specifically, the porous resin adsorbent on which the licorice extract is adsorbed and a solvent (preferably 70 to 98% by weight of an ethanol aqueous solution) are put together and stirred (dissolved) in a vessel provided with a stirrer. Preferably it is a continuous flow using a column. Specifically, the porous resin adsorbent on which licorice extract is adsorbed is filled into the column, and then contacted (dissolved) by continuously passing a solvent (preferably 70 to 98% by weight of an ethanol aqueous solution) through the column. . In the case of continuous flow using a column, the process is more monotonous than a batch and can proceed continuously with the adsorption step. As described above, the adsorption step is a continuous flow formula using the column in terms of process efficiency, in this case, if the desorption step also uses the column, it can proceed to the method of passing the solvent through the column immediately after the adsorption, adsorption and desorption Can proceed continuously.
상기한 바와 같이, 본 발명에 따르면 다공질의 레진 흡착제를 통한 흡착에 의해, 감초 추출물 중에 잔존하는 글리시리진이 2차적으로 분리 제거된다. 즉, 열수 추출을 통해 1차 분리 제거되고, 다공질의 레진 흡착제를 통한 흡착 분리에 의해 2차 제거된다. 이에 따라, 본 발명에 따르면, 전술한 바와 같이 최종적으로 수득된 감초 추출물, 즉 흡착단계 및 탈착단계를 거쳐 수득된 감초 추출물에는 글리시리진의 함량이 1.0중량% 이하, 구체적으로는 0(zero)중량% 내지 1.0중량%이다. 바람직하게는, 0(zero)중량%로서 글리시리진이 효과적으로 제거된다. 이와 같이 글리시리진이 효과적으로 제거된 감초 추출물은 이하에서 설명하는 바와 같이 항충치 조성물에 이용될 수 있다. As described above, according to the present invention, by the adsorption through the porous resin adsorbent, the remaining glycyrrhizin in the licorice extract is secondarily removed. That is, primary separation is removed by hot water extraction, and secondary removal is performed by adsorptive separation through a porous resin adsorbent. Accordingly, according to the present invention, the licorice extract finally obtained as described above, that is, the licorice extract obtained through the adsorption step and the desorption step, the content of glycyrizine is 1.0% by weight or less, specifically 0 (zero)% by weight To 1.0% by weight. Preferably, glycyrazine is effectively removed as zero weight percent. Licorice extract, in which glycyrrhizin has been effectively removed, can be used in anti-cavity compositions as described below.
이하, 본 발명에 따른 감초 추출물의 제조방법, 및 이에 따라 제조된 감초 추출물, 그리고 상기 감초 추출물을 포함하는 항충치 조성물을 설명한다. Hereinafter, a method for preparing a licorice extract according to the present invention, and a licorice extract prepared according to the present invention, and an anti-cavity composition comprising the licorice extract.
먼저, 본 발명에 따른 감초 추출물의 제조방법은, 상기 글리시리진 제거방법에서 설명한 4개의 단계를 적어도 포함한다. 구체적으로, 감초를 열수 추출하는 제1차 추출단계; First, the method for preparing licorice extract according to the present invention includes at least four steps described in the above-described glycidazine removal method. Specifically, the first extraction step of extracting hot water licorice;
상기 제1차 추출하여 얻어진 감초와 추출액의 혼합물을 여과하여 감초를 분리하고 분리된 감초에 유기 용매를 가한 다음 가열하여 추출하는 제2차 추출단계; A second extraction step of filtering the mixture of licorice and extract obtained by the first extraction to separate licorice, adding an organic solvent to the separated licorice, and then heating and extracting it;
상기 제2차 추출하여 얻어진 감초와 추출액의 혼합물을 여과하여 추출액을 분리한 후, 분리된 추출액을 소수성인 다공질의 레진 흡착제와 접촉시켜 약리 활성 유효성분을 흡착하는 흡착단계; 및 An adsorption step of filtering the mixture of licorice and extract obtained by the second extraction to separate the extract and then adsorbing the separated extract with a hydrophobic porous resin adsorbent to adsorb pharmacologically active ingredients; And
상기 약리 활성 유효성분이 흡착된 다공질의 레진 흡착제를 용매와 접촉시켜 약리 활성 유효성분이 용매에 용해되도록 하여 분리시키는 탈착단계를 포함한다. 이들 각 단계는 전술한 바와 같으므로, 이에 대한 구체적인 설명은 생략한다. And a desorption step of separating the pharmacologically active active ingredient by dissolving it in contact with a solvent by contacting the porous resin adsorbent to which the pharmacologically active active ingredient is adsorbed. Since each of these steps is as described above, a detailed description thereof will be omitted.
바람직한 구현예에 따라서, 본 발명에 따른 감초 추출물의 제조방법은 상기 3개의 단계(제1차 추출단계, 제2차 추출단계, 흡착단계 및 탈착단계)에 후속하여 진행되는 것으로서, 상기 감초 추출물을 농축하는 단계를 더 포함할 수 있다. 구체적으로, 상기 탈착단계를 용매에 접촉(용해)시키는 방법으로 진행한 경우, 감초 추출물에는 용매(에탄올 수용액)가 포함되어 있는데, 이 경우 감초 추출물의 용도에 따라 30 ~ 100℃의 온도로 가열하여 농축하는 단계(농축단계)를 더 포함할 수 있다. 이때, 농축 시의 가열 온도가 30℃ 미만인 경우 용매의 휘발성이 낮아 농축 시간이 오래 걸릴 수 있고, 100℃를 초과하는 경우 용매와 함께 항충치 성분 등의 약리 활성 유효성분도 휘발될 수 있다. According to a preferred embodiment, the method for preparing licorice extract according to the present invention is to be carried out after the three steps (the first extraction step, the second extraction step, the adsorption step and the desorption step), the licorice extract Concentrating may be further included. Specifically, when the desorption step is carried out by a method of contacting (dissolving) a solvent, the licorice extract contains a solvent (ethanol aqueous solution), in which case it is heated to a temperature of 30 ~ 100 ℃ according to the use of licorice extract Concentrating step (concentration step) may further include. At this time, when the heating temperature at the time of concentration is less than 30 ℃ low volatility of the solvent may take a long time to concentrate, if it exceeds 100 ℃ may also be volatile pharmacologically active active ingredients such as anti-cavities components.
상기 농축단계는 감압 하에서 진행되는 것이 좋은데, 예를 들어 상기 온도 범위 내에서 10 ~ 700Torr의 압력 하에서 진행되는 것이 좋다. 이러한 압력 범위에서 농축하는 경우 농축 효율 면에서 유리하다. 그리고 상기 농축단계에서 가열 시간은, 특별히 한정하는 것은 아니지만 상기 온도 범위 내에서 10분 ~ 8시간이 될 수 있다. 이때, 가열 시간이 10분 미만인 경우, 농축 효율이 떨어지고, 8시간을 초과하는 경우 과잉 시간에 따른 상승효과가 그다지 크지 않고 에너지 비용 면에서 바람직하지 않을 수 있다. The concentration step is preferably carried out under reduced pressure, for example, it is preferably carried out under a pressure of 10 ~ 700 Torr within the temperature range. Concentration in this pressure range is advantageous in terms of concentration efficiency. The heating time in the concentration step is not particularly limited, but may be 10 minutes to 8 hours within the temperature range. In this case, when the heating time is less than 10 minutes, the concentration efficiency is lowered, and when more than 8 hours, the synergistic effect according to the excess time is not so large and may be undesirable in terms of energy cost.
아울러, 위와 같은 농축단계를 통해 농축된 추출물은, 필요에 따라 자연 건조, 열풍 건조 또는 동결 건조 등을 통해 건조될 수 있다. 그리고 건조된 추출물은 분말화된 상태로 제품화되거나, 항충치 조성물 등의 각종 제형 조성물에 혼합될 수 있다. In addition, the extract concentrated through the concentration step as described above, may be dried through natural drying, hot air drying or freeze drying, if necessary. The dried extract may be commercialized in a powdered state or mixed in various formulation compositions, such as anti-cavity compositions.
또한, 본 발명에 따른 감초 추출물의 제조방법은 상기 농축된 추출물에 부형제를 첨가하는 단계를 더 포함하는 것이 좋다. 이때, 상기 부형제는 감초 추출물에 수용성을 부여하거나, 농축을 위한 점도 조절제로 작용하는 것으로서, 이는 수용성의 당류 또는 지방산류 등으로부터 선택될 수 있다. 부형제는, 예를 들어 카라기난, 유당, 덱스트린, 싸이클로 덱스트린, 카제인, 펙틴, 산탄 검 및 펙틴 등으로부터 선택된 하나 이상을 사용할 수 있다. 이러한 부형제는, 농축된 추출물 100중량부에 대하여 예를 들어 1 ~ 100중량부로 첨가될 수 있다. 이때, 부형제의 첨가량이 1중량부 미만인 경우, 이의 첨가에 따른 수용성 부여나 점도 조절능(농축)이 미미할 수 있다. 그리고 부형제의 첨가량이 100중량부를 초과하는 경우, 상대적으로 감초 추출물의 함량이 낮아져, 감초 추출물의 사용에 따른 항충치 개선 효과 등이 미미할 수 있다. In addition, the method for preparing licorice extract according to the present invention may further comprise adding an excipient to the concentrated extract. At this time, the excipient imparts water solubility to the licorice extract, or acts as a viscosity regulator for concentration, it may be selected from water-soluble sugars or fatty acids. Excipients can be used, for example, one or more selected from carrageenan, lactose, dextrin, cyclodextrin, casein, pectin, xanthan gum and pectin and the like. Such excipients may be added, for example, from 1 to 100 parts by weight based on 100 parts by weight of the concentrated extract. At this time, when the addition amount of the excipient is less than 1 part by weight, water solubility provision or viscosity control ability (concentration) may be insignificant according to the addition thereof. And when the addition amount of the excipient exceeds 100 parts by weight, the content of the licorice extract is relatively low, the anti-cavity improvement effect according to the use of licorice extract may be insignificant.
아울러, 위와 같이 부형제가 첨가된 감초 추출물은, 전술한 바와 같이 필요에 따라 자연 건조, 열풍 건조 또는 동결 건조 등을 통해 건조될 수 있다. 그리고 건조된 추출물은 분말화된 상태로 제품화되거나, 항충치 조성물 등의 각종 제형 조성물에 혼합될 수 있다. In addition, the licorice extract to which the excipient is added as described above, may be dried through natural drying, hot air drying or freeze drying, as needed. The dried extract may be commercialized in a powdered state or mixed in various formulation compositions, such as anti-cavity compositions.
한편, 본 발명에 따른 감초 추출물은 글리시리진이 제거된 것으로서, 상기한 바와 같은 본 발명에 따른 감초 추출물의 제조방법에 따라 제조되어, 글리시리진이 없거나 매우 낮은 함량으로 포함한다. 구체적으로, 본 발명에 따른 감초 추출물은 상기와 같은 방법으로 제조되어, 항충치 성분 등의 약리 활성 성분을 유효성분으로 포함하되, 1.0중량% 이하의 글리시리진을 포함한다. 바람직하게는, 글리시리진이 효과적으로 제거되어, 글리시리진의 함량이 0(zero)중량%이다. On the other hand, the licorice extract according to the present invention is a glycyrrhigin is removed, prepared according to the method for producing a licorice extract according to the present invention as described above, and contains no or very low content of glycyrrhizin. Specifically, the licorice extract according to the present invention is prepared by the same method as described above, and includes pharmacologically active ingredients such as anti-cavities as an active ingredient, but contains less than 1.0% by weight of glycidazine. Preferably, glycyrrhizin is effectively removed so that the content of glycyrrhizine is zero weight percent.
또한, 본 발명에 따른 감초 추출물의 제형은 제한되지 않는다. 본 발명에 따른 감초 추출물은, 예를 들어 액상, 페이스트상, 분말상(고상) 등으로부터 선택될 수 있다. 일례로, 상기한 바와 같이 농축 후, 건조를 통해 분말상의 제형을 가질 수 있다. In addition, the formulation of the licorice extract according to the present invention is not limited. Licorice extract according to the present invention may be selected from, for example, liquid, paste, powder (solid) and the like. For example, after concentration as described above, it may have a powdery formulation through drying.
본 발명에 따른 감초 추출물은 위와 같이 글리시리진이 효과적으로 제거되어, 글리시리진에 따른 부작용이 없다. 아울러, 본 발명에 따른 감초 추출물은 당이 있는 상태, 예를 들어 글루코스(glucose)나 수크로즈(sucrose) 등의 당이 있는 상태에서도 스트렙토코커스 뮤탄스(S.mutans) 균 등의 충치 유발균의 생육을 효과적으로 억제한다. 이에 따라, 본 발명에 따른 감초 추출물은 당 성분이 많이 포함되어 있는 과자류, 사탕류, 캔디류, 초콜릿류 및 껌류 등의 식품에 치아 우식을 억제하기 위한 항충치 유효 성분으로 유용하게 적용(포함)될 수 있다. Licorice extract according to the present invention is effectively removed as described above glycerin, there is no side effect due to glycyrrhizin. In addition, the licorice extract according to the present invention is in the presence of sugars, for example, in the presence of sugars such as glucose (glucose) or sucrose (sucrose) of caries-inducing bacteria such as Streptococcus mutans (S.mutans) bacteria It effectively suppresses growth. Accordingly, the licorice extract according to the present invention can be usefully applied (included) as an anti-carcinoma active ingredient for inhibiting dental caries in foods such as confectionary, candy, candy, chocolate and gum containing a lot of sugar components. have.
또한, 본 발명에 따른 항충치 조성물은, 상기 본 발명의 감초 추출물을 포함한다. 본 발명에서 항충치 조성물의 제형은 제한되지 않는다. 본 발명에 따른 항충치 조성물은 상기 본 발명의 감초 추출물을 포함하여, 항충치 성능(항균성)을 가지는 것이면 제한되지 않으며, 예를 들어 약리학적 조성물, 식품용 조성물 및 구강용 조성물 등으로부터 선택될 수 있다. 예를 들어, 상기 식품용 조성물은 과자류, 사탕류, 캔디류, 초콜릿류 및 껌류 조성물 등을 예로 들 수 있다. 그리고 상기 구강용 조성물은 치약 조성물 및 구강 세정 조성물 등을 예로 들 수 있다. 일례를 들어, 본 발명에 따른 항충치 조성물이 치약 조성물인 경우, 본 발명에 따른 항충치 조성물은 치약 베이스 성분 및 상기 본 발명의 감초 추출물을 포함한다. 이때, 상기 치약 베이스 성분은 통상적인 치약 조성물을 구성하는 것으로서, 이는 예를 들어 연마제 및 계면활성제 등을 포함할 수 있다. In addition, the anti-cavities composition according to the present invention, the licorice extract of the present invention. The formulation of the anti-cavities composition in the present invention is not limited. The anti-cavities composition according to the present invention, including the licorice extract of the present invention, is not limited as long as it has anti-cavities performance (antibacterial), for example, it can be selected from pharmacological compositions, food compositions and oral compositions and the like. have. For example, the food composition may include sweets, candy, candy, chocolate, gum composition, and the like. The oral composition may include, for example, a toothpaste composition and an oral cleaning composition. For example, when the anti-cavities composition according to the present invention is a toothpaste composition, the anti-cavities composition according to the present invention comprises a toothpaste base component and the licorice extract of the present invention. In this case, the toothpaste base component constitutes a conventional toothpaste composition, which may include, for example, an abrasive and a surfactant.
아울러, 본 발명에 따른 항충치 조성물은, 조성물 전체 중량 기준으로 상기 감초 추출물을 1.0ppm ~ 10.0중량%로 포함할 수 있다. 이때, 감초 추출물의 함량이 1.0ppm 미만인 경우, 감초 추출물의 함유에 따른 항충치 등의 효과가 미미할 수 있고, 10.0중량%를 초과하는 경우 감초 추출물의 함량 증가에 따른 항충치 기능 차이가 크지 않고 조성물의 제형에 영향을 줄 수 있다. 이러한 점을 고려할 때, 상기 감초 추출물은 항충치 조성물 전체 중량 기준으로 30 ~ 100ppm으로 포함되는 것이 바람직하다. In addition, the anti-cavity composition according to the present invention, the total licorice extract may comprise 1.0 ppm to 10.0% by weight based on the total weight of the composition. At this time, if the content of licorice extract is less than 1.0ppm, the effect such as anti-cavities according to the content of licorice extract may be insignificant, and if the content exceeds 10.0% by weight, the anti-cariogenic function difference according to the increase of the content of licorice extract is not large May affect the formulation of the drug. In consideration of this point, the licorice extract is preferably included in 30 ~ 100ppm based on the total weight of the anti-cavities composition.
이상에서 설명한 본 발명에 따르면, 열수 추출 및 유기 용매 추출 후, 다공질의 레진 흡착제를 통한 흡착 분리에 의해 감초 중의 글리시리진이 효과적으로 제거된다. 이에 따라, 부작용이 없는 감초 추출물을 제공할 수 있다. According to the present invention as described above, after hydrothermal extraction and organic solvent extraction, glycyrrhizin in licorice is effectively removed by adsorptive separation through a porous resin adsorbent. Accordingly, it is possible to provide a licorice extract having no side effects.
이하, 본 발명의 실시예를 예시한다. 하기의 실시예는 본 발명의 이해를 돕도록 하기 위해 제공되는 것일 뿐, 이에 의해 본 발명의 기술적 범위가 한정되는 것은 아니다. Hereinafter, the Example of this invention is illustrated. The following examples are merely provided to aid the understanding of the present invention, whereby the technical scope of the present invention is not limited.
[실시예]EXAMPLE
< 열수 및 용매 추출 >Hot Water and Solvent Extraction
건조된 감초 뿌리 50g에 1L의 물을 혼합하여 상압, 90℃의 온도에서 2시간동안 3회 열수 추출하였다. 그리고 열수 추출한 감초를 여과하여, 추출액은 분리 제거하고, 여과 후 남은 감초에 감초 무게 15배의 75중량% 에탄올 수용액을 가하여 감압, 85℃의 온도에서 2시간동안 추출하였다. 1 g of water was mixed with 50 g of dried licorice root, and extracted with hot water three times at a temperature of 90 ° C. for 2 hours. Then, the licorice extracted by hot water was filtered, the extract was separated and removed, and an aqueous solution of 75 wt% ethanol having 15 times the weight of licorice was added to the remaining licorice after filtration and extracted for 2 hours at a reduced pressure and a temperature of 85 ° C.
*< 흡착 및 탈착 >* <Adsorption and desorption>
다음으로, 상기 에탄올 수용액으로 추출하여 얻어진 추출액에 6L의 물을 가하여 혼합하여 희석시킨 다음, 상기 희석된 추출액을 다공질의 레진 흡착제가 충전된 컬럼에 통과시켜 1차 접촉시켰다. 이때, 상기 컬럼은 다공질의 레진 흡착제로서 HP20(일본, 미츠비시 케미컬社 제품을 사용할 수 있다.)을 충전하여 사용하였다. Next, 6 L of water was added to the extract obtained by extraction with the ethanol aqueous solution, followed by mixing and diluting. Then, the diluted extract was passed through a column filled with a porous resin adsorbent for primary contact. At this time, the column was used as a porous resin adsorbent filled with HP20 (Japan, Mitsubishi Chemical can use).
위와 같이, 1차 접촉된 추출액을 수득한 다음, 여기에 50중량% 에탄올 수용액 2,600ml를 가하여 혼합한 다음, 상기 컬럼에 재차 통과시켜 2차 접촉시켰다. As above, after obtaining the first contacted extract, 2,600 ml of a 50% by weight aqueous solution of ethanol was added thereto, mixed, and passed through the column again to make a second contact.
후속하여, 상기 컬럼에 95중량% 에탄올 수용액 2,500ml를 통과시켜 다공질의 레진 흡착제에 흡착된 약리 활성 유효성분인 감초 추출물을 용해시켰다. Subsequently, 2,500 ml of a 95 wt% ethanol aqueous solution was passed through the column to dissolve licorice extract, a pharmacologically active ingredient adsorbed on the porous resin adsorbent.
< 농축 및 건조 ><Concentration and drying>
그리고 컬럼을 통과한 감초 추출물을 수득한 다음, 이를 85℃의 온도에서 8시간 동안 감압 하에서 농축하였다. 이후, 농축된 감초 추출물에 부형제로서 농축 추출물 전체 무게 10중량%의 카라기난을 첨가, 농축하여 페이스트상태의 추출물을 얻었다. 다음으로 -50℃, 15Torr에서 3일 간 동결 건조하여 분말 상태의 감초 추출물을 제조하였다. Then, a licorice extract obtained through the column was obtained, and it was concentrated under reduced pressure for 8 hours at a temperature of 85 ° C. Thereafter, carrageenan (10 wt% total weight of the concentrated extract) was added to the concentrated licorice extract as an excipient and concentrated to obtain a paste extract. Next, lyophilized for 3 days at -50 ℃, 15 Torr to prepare a licorice extract in powder form.
[비교예 1]Comparative Example 1
상기 실시예와 비교하여, 열수 추출, 흡착 및 탈착을 실시하지 않는 것을 제외하고는 동일하게 실시하였다. 구체적으로, 감초를 열수 추출하지 않고 에탄올 추출을 실시하였다. 이후, 레진 흡착제(HP20)에 접촉시키지 않고, 곧바로 농축을 실시한 다음, 부형제(카라기난)를 첨가한 후, 동결 건조한 것을 본 비교예 1에 따른 감초 추출물 시편으로 사용하였다. Compared with the above examples, the same procedure was followed except that hot water extraction, adsorption and desorption were not performed. Specifically, licorice was extracted without hot water extraction. Thereafter, the mixture was immediately concentrated without contacting the resin adsorbent (HP20), and then an excipient (carrageenan) was added, followed by freeze drying, which was used as a licorice extract specimen according to Comparative Example 1.
[비교예 2]Comparative Example 2
상기 실시예와 비교하여, 흡착 및 탈착을 실시하지 않는 것을 제외하고는 동일하게 실시하였다. 구체적으로, 감초를 열수 추출과 에탄올 추출을 연속적으로 실시한 후, 레진 흡착제(HP20)에 접촉시키지 않고, 곧바로 농축시켰다. 그리고 농축 후, 부형제(카라기난)를 첨가한 다음, 동결 건조한 것을 본 비교예 2에 따른 감초 추출물 시편으로 사용하였다. Compared with the above examples, the same procedure was followed except that adsorption and desorption were not performed. Specifically, licorice was concentrated immediately after performing hot water extraction and ethanol extraction, without contacting the resin adsorbent (HP20). After concentration, an excipient (carrageenan) was added, and then lyophilized was used as a licorice extract specimen according to Comparative Example 2.
상기 각 실시예 및 비교예에 따라 제조된 감초 추출물에 대하여, HPLC(High-Pressure Liquid Chromatography)를 이용하여 글리시리진의 함량을 측정하고, 그 결과를 하기 [표 1]에 나타내었다. 하기 [표 1]의 함량(중량%)은 감초 추출물 전체 중량을 기준으로 한 것이다. For licorice extracts prepared according to the above Examples and Comparative Examples, the content of glycyrrhizin was measured using HPLC (High-Pressure Liquid Chromatography), and the results are shown in the following [Table 1]. The content (% by weight) of the following [Table 1] is based on the total weight of licorice extract.
표 1 < 감초 추출물의 글리시리진 함량 >
구 분 글리시리진 함량(중량%)
실시예 0(불검출)
비교예 1 4.8645
비교예 2 2.2056
Table 1 <Glycirizine Contents of Licorice Extracts>
division Glycyrrhizin content (% by weight)
Example 0 (not detected)
Comparative Example 1 4.8645
Comparative Example 2 2.2056
상기 [표 1]에 보인 바와 같이, 비교예 1에서와 같이 에탄올 추출만 실시한 경우, 4중량% 이상으로서 높은 함량의 글리시리진을 함유하고 있음을 알 수 있다. 그리고 열수 추출과 에탄올 추출을 연속적으로 실시한 비교예 2의 경우, 글리시리진의 함량이 비교예 1보다 감소하기는 하나, 2중량% 이상으로서 효과적으로 제거되지 않음을 알 수 있다. 그러나 본 발명의 실시예에 따라 열수 및 에탄올 추출 후, 다공질의 레진 흡착제(HP20)에 접촉시키는 경우, 글리시리진의 함량이 0(불검출)으로서 효과적으로 제거됨을 알 수 있다. As shown in Table 1 above, when only ethanol extraction was carried out as in Comparative Example 1, it can be seen that it contains a high content of glycyrrhizin as 4% by weight or more. And in the case of Comparative Example 2 subjected to hot water extraction and ethanol extraction continuously, it can be seen that the content of glycyrizine is less than 2% by weight, but is not effectively removed. However, after contact with the porous resin adsorbent (HP20) after hot water and ethanol extraction according to an embodiment of the present invention, it can be seen that the content of glycyrrhizin is effectively removed as 0 (not detected).
또한, 첨부된 도 1은 상기 실시예에 따라 제조된 감초 추출물의 농도에 따른 항균 평가 결과를 보인 그래프로서, MIC(Minimum Inhibitory Concentration) 결과를 O.D(Optical Density) 값으로 나타낸 그래프이다. 이때, 항균 평가 결과는 충치 유발균인 스트렙토코커스 뮤탄스(S.mutans) 균을 이용하되, NCCLS(Nation Committee of Clinical Laboratory Standard)에서 추천하는 MIC(Minimum Inhibitory Concentration) 실험 방법으로 다음과 같이 실시하였다. In addition, Figure 1 is a graph showing the results of the antimicrobial evaluation according to the concentration of licorice extract prepared according to the embodiment, the graph showing the MIC (Minimum Inhibitory Concentration) results as O.D (Optical Density) value. At this time, the antimicrobial evaluation results were performed using the Streptococcus mutans (S.mutans), a decay-inducing bacterium, as the MIC (Minimum Inhibitory Concentration) test method recommended by the National Committee of Clinical Laboratory Standard (NCCLS) as follows. .
1. 감초 추출물을 에탄올에 용해하여 10mg/ml의 농도가 되게 함 1. Dissolve licorice extract in ethanol to a concentration of 10mg / ml
2. 고압멸균 처리한 증류수로 1/10배 희석하여 1mg/ml의 농도가 되게 함 2. Dilute 1 / 10-fold with autoclaved distilled water to a concentration of 1mg / ml
3. Triptic Soy Broth(TSB) 배지로 원하는 농도로 희석(30ppm, 40ppm, 50ppm, 60ppm, 70ppm, 80ppm, 90ppm 및 100ppm) 3. Dilute to desired concentration with Triptic Soy Broth (TSB) medium (30ppm, 40ppm, 50ppm, 60ppm, 70ppm, 80ppm, 90ppm and 100ppm)
4. 희석한 감초 추출물을 96-웰플레이트에 150㎕씩 단계 별로 분주 4. Dispense the diluted licorice extract into the 96-well plates in 150 µl steps.
5. 스트렙토코커스 뮤탄스(S.mutans) 균을 TSB 배지에서 37℃, 혐기조건(anaerobic conditions)으로 배양 5. Streptococcus mutans cultured in anaerobic conditions at 37 ℃ in TSB medium
6. 106 colony-forming units/ml농도의 스트렙토코커스 뮤탄스(S.mutans) 균이 포함된 배지를 96-웰플레이트(단계별로 희석된 감초 추출물)에 150㎕ 씩 분주 6. Dispense 150 μl of medium containing Streptococcus mutans at a concentration of 10 6 colony-forming units / ml into a 96-well plate (diluted licorice extract).
7. 즉시 O.D 값을 측정하고, 배양 전에 한 번 더 O.D 값을 측정 7. Immediately measure O.D values and measure O.D one more time before incubation
8. 37℃의 혐기조건에서 배양하여 16시간, 24시간, 40시간 마다 O.D 값을 측정하여 그래프를 얻음8. Incubate in anaerobic condition at 37 ℃ and measure O.D value every 16 hours, 24 hours, 40 hours to obtain graph
첨부된 도 1에 나타난 바와 같이, 본 발명에 의한 감초 추출물은 스트렙토코커스 뮤탄스(S.mutans) 균에 대한 항균성(항충치 성능)을 가짐을 확인할 수 있었다. 또한, 항균성(O.D 값)은 감초 추출물의 농도가 높아질수록 증가함을 알 수 있었다. 아울러, 도 1의 그래프에 나타난 바와 같이, 본 발명의 실시예에 따른 감초 추출물은 30ppm 및 40ppm의 저농도에서도 스트렙토코커스 뮤탄스(S.mutans) 균의 활성을 억제하여 우수한 항균성을 가짐을 알 수 있었다. As shown in FIG. 1, the licorice extract according to the present invention was confirmed to have antimicrobial activity against the Streptococcus mutans (S.mutans). In addition, the antimicrobial (O.D value) was found to increase as the concentration of licorice extract increases. In addition, as shown in the graph of Figure 1, the licorice extract according to the embodiment of the present invention was found to have excellent antimicrobial activity by inhibiting the activity of Streptococcus mutans (S.mutans) even at low concentrations of 30ppm and 40ppm .
한편, 상기 실시예에 따라 제조된 감초 추출물에 대하여, 글루코스(glucose)와 수크로즈(sucrose)의 당 존재 하에서의 스트렙토코커스 뮤탄스(S.mutans) 균의 생육 억제 효과를 알아보기 위하여, 바이오필름(Biofilm)을 이용하여 O.D값을 측정하였다. 그 결과를 첨부된 도 2 및 도 3에 나타내었다. 도 2는 글루코스(glucose)의 존재 하에서 실시한 측정 결과를 보인 그래프이고, 도 3은 수크로즈(sucrose)의 존재 하에서 실시한 측정 결과를 보인 그래프이다. On the other hand, with respect to the licorice extract prepared according to the above embodiment, in order to determine the growth inhibitory effect of Streptococcus mutans (S.mutans) bacteria in the presence of glucose (glucose) and sucrose (sucrose), biofilm ( Biofilm) was used to measure the OD value. The results are shown in FIGS. 2 and 3. Figure 2 is a graph showing the measurement results performed in the presence of glucose (glucose), Figure 3 is a graph showing the measurement results performed in the presence of sucrose (sucrose).
바이오필름은 24-well 폴리스티렌(flat-bottom) 셀 배양 클러스터(Costar 3596; Corning 社 제품)를 이용하였다. 그리고 바이오필름에 스트렙토코커스 뮤탄스(S.mutans) 균을 OD600 = 0.5까지 성장시켰다. Biofilm used a 24-well polystyrene (flat-bottom) cell culture cluster (Costar 3596; manufactured by Corning). The biofilms were grown to Streptococcus mutans (S.mutans) to OD 600 = 0.5.
먼저, 글루코스(glucose)의 존재 하에서 스트렙토코커스 뮤탄스(S.mutans) 균의 생육 억제 효과를 알아보고자, 상기 실시예에 따라 제조된 감초 추출물을 각 농도(10 ~ 100ppm)별로 2mL의 타액(Saliva)에 투입하고, 여기에 20 mM의 글루코스(glucose)를 가하였다. 도 2의 그래프에서 'Saliva coating'은, 감초 추출물이 포함된 타액(Saliva)을 바이오필름에 코팅한 후 세균(S.mutans)을 배양한 결과이다. 그리고 도 2의 그래프에서 'Saliva adding'은, 감초 추출물이 포함된 타액(Saliva)과 세균(S.mutans)을 함께 배양한 결과이다. 이때, 세균(S.mutans)의 배양은 37℃, 5wt% CO2 환경에서 48시간 동안 실시하였다. 또한, 감초 추출물을 사용하지 않은 무처리 시편(도 2의 그래프에서 'No saliva treatment')과 비교하였다. First, to determine the growth inhibitory effect of Streptococcus mutans (S.mutans) in the presence of glucose (glucose), 2mL saliva (Saliva) of licorice extract prepared according to the above example at each concentration (10 ~ 100ppm) ) And 20 mM glucose was added thereto. In the graph of FIG. 2, 'Saliva coating' is a result of culturing bacteria (S.mutans) after coating saliva (Saliva) containing licorice extract on a biofilm. In the graph of FIG. 2, 'Saliva adding' is a result of incubating saliva (Saliva) and bacteria (S.mutans) together with licorice extract. At this time, the culture of bacteria (S.mutans) was carried out for 48 hours in 37 ℃, 5wt% CO 2 environment. In addition, the licorice extract was compared to the untreated specimens ('No saliva treatment' in the graph of Figure 2).
도 2에 나타난 바와 같이, 상기 실시예에 따라 제조된 감초 추출물은 글루코스(glucose)의 존재 하에서 스트렙토코커스 뮤탄스(S.mutans) 균에 대한 생육 억제 효과를 가짐을 알 수 있었다. 특히, 20ppm의 낮은 농도에서도 생육 억제 효과를 가짐을 알 수 있었다. As shown in Figure 2, the licorice extract prepared according to the embodiment was found to have a growth inhibitory effect on the Streptococcus mutans (S.mutans) bacteria in the presence of glucose (glucose). In particular, it can be seen that it has a growth inhibitory effect even at a low concentration of 20ppm.
또한, 수크로즈(sucrose)의 존재 하에서 스트렙토코커스 뮤탄스(S.mutans) 균의 생육 억제 효과를 알아보기 위하여, 상기와 동일한 방법으로 O.D 값을 평가하고 그 결과를 첨부된 도 3에 그래프로 나타내었다. 도 3의 그래프에서 'Saliva coating'은 코팅한 후 세균(S.mutans)을 배양한 결과이고, 'Saliva adding'은 세균(S.mutans)과 함께 배양한 결과이다. 그리고 'No saliva treatment'는 감초 추출물을 사용하지 않은 무처리 시편의 결과이다. In addition, in order to determine the growth inhibitory effect of S. mutans bacteria in the presence of sucrose, the OD value was evaluated in the same manner as above and the results are shown graphically in FIG. It was. In the graph of FIG. 3, 'Saliva coating' is the result of culturing bacteria (S.mutans) after coating, 'Saliva adding' is the result of culturing with bacteria (S.mutans). 'No saliva treatment' is the result of untreated specimens without licorice extract.
도 3에 나타난 바와 같이, 상기 실시예에 따라 제조된 감초 추출물은 수크로즈(sucrose) 존재 하에서 스트렙토코커스 뮤탄스(S.mutans) 균의 생육 억제 효과를 가짐을 알 수 있었다. 그리고 coating의 경우에는 낮은 농도에서도 양호한 결과를 가졌으며, adding의 경우에는 감초 추출 농도 50ppm 이상에서 양호한 결과를 가짐을 알 수 있었다. As shown in FIG. 3, the licorice extract prepared according to the embodiment was found to have a growth inhibitory effect of Streptococcus mutans bacteria in the presence of sucrose. In case of coating, good results were obtained even at low concentrations, and in the case of adding, good results were obtained at concentrations of more than 50 ppm of licorice extract.
이상의 실험예를 통해 확인되는 바와 같이, 본 발명에 따라 제조된 감초 추출물은 글루코스(glucose)나 수크로즈(sucrose) 등의 당이 있는 상태에서도 스트렙토코커스 뮤탄스(S.mutans) 균의 생육을 효과적으로 억제함을 알 수 있다. 이에 따라, 과자나 캔디, 초콜릿 등과 같이 당의 함량이 많은 식품에도 유용하게 적용될 수 있음을 알 수 있다.As confirmed through the above experimental example, licorice extract prepared according to the present invention is effective in the growth of Streptococcus mutans (S.mutans) even in the presence of sugars such as glucose (glucose) or sucrose (sucrose) It can be seen that. Accordingly, it can be seen that it can be usefully applied to foods with a high content of sugar such as sweets, candy, chocolate, and the like.

Claims (16)

  1. 감초를 열수 추출하는 제1차 추출단계; A first extraction step of extracting hot water from licorice;
    상기 제1차 추출하여 얻어진 감초와 추출액의 혼합물을 여과하여 감초를 분리하고 분리된 감초에 유기 용매를 가한 다음 가열하여 추출하는 제2차 추출단계; A second extraction step of filtering the mixture of licorice and extract obtained by the first extraction to separate licorice, adding an organic solvent to the separated licorice, and then heating and extracting it;
    상기 제2차 추출하여 얻어진 감초와 추출액의 혼합물을 여과하여 추출액을 분리한 후, 분리된 추출액을 소수성인 다공질의 레진 흡착제와 접촉시켜 약리 활성 유효성분을 흡착하는 흡착단계; 및 An adsorption step of filtering the mixture of licorice and extract obtained by the second extraction to separate the extract and then adsorbing the separated extract with a hydrophobic porous resin adsorbent to adsorb pharmacologically active ingredients; And
    상기 약리 활성 유효성분이 흡착된 다공질의 레진 흡착제를 용매와 접촉시켜 약리 활성 유효성분이 용매에 용해되도록 하여 분리시키는 탈착단계;를 포함하는 것을 특징으로 하는 감초의 글리시리진 제거방법.A desorption step of separating the pharmacologically active active ingredient is dissolved in a solvent by contacting the porous resin adsorbent adsorbed to the pharmacologically active active ingredient so as to dissolve in the solvent.
  2. 제1항에 있어서, The method of claim 1,
    상기 흡착단계는, 상기 제2차 추출에서 분리된 추출액에 희석 용매를 가하여 희석시킨 다음, 다공질의 레진 흡착제와 접촉시키는 것을 특징으로 하는 감초의 글리시리진 제거방법.Said adsorption step, diluting by adding a dilution solvent to the extract separated in the second extraction, and then contacting with a porous resin adsorbent, licorice glycidazine removal method.
  3. 제1항에 있어서, The method of claim 1,
    상기 흡착단계는,The adsorption step is
    (a) 상기 제2차 추출에서 분리된 추출액에 물을 가하여 희석시킨 다음, 다공질의 레진 흡착제와 제1차 접촉시키는 공정; 및 (a) adding water to and diluting the extract separated in the second extraction, followed by first contact with a porous resin adsorbent; And
    (b) 상기 제1차 접촉된 추출액에 30 ~ 60중량%의 에탄올 수용액을 가하여 희석시킨 다음, 다공질의 레진 흡착제와 제2차 접촉시키는 공정을 포함하는 것을 특징으로 하는 감초의 글리시리진 제거방법.(b) adding a dilute solution of 30 to 60% by weight of ethanol to the first contacted extract, followed by a second contact with a porous resin adsorbent for licorice glycidazine removal.
  4. 제1항 내지 제3항 중 어느 하나의 항에 있어서,The method according to any one of claims 1 to 3,
    상기 흡착단계는, 다공질의 레진 흡착제가 충전된 컬럼에 추출액을 통과시켜 접촉시키는 것을 특징으로 하는 감초의 글리시리진 제거방법.The adsorption step, Glycyrrhizine removal method of licorice, characterized in that the extract is passed through a column filled with a porous resin adsorbent.
  5. 제1항 내지 제3항 중 어느 하나의 항에 있어서,The method according to any one of claims 1 to 3,
    상기 탈착단계는, 70 ~ 98중량%의 에탄올 수용액을 이용하여 다공질의 레진 흡착제로부터 약리활성 유효성분을 분리시키는 것을 특징으로 하는 감초의 글리시리진 제거방법.The desorption step, Glycirizine removal method of licorice, characterized in that to separate the pharmacologically active ingredient from the porous resin adsorbent using 70 ~ 98% by weight of ethanol aqueous solution.
  6. 제1항 내지 제3항 중 어느 하나의 항에 있어서,The method according to any one of claims 1 to 3,
    상기 다공질의 레진 흡착제는 스티렌-디비닐벤젠, 메타크릴레이트 및 이들의 유도체 중에서 선택된 하나 이상을 포함하는 것을 특징으로 하는 감초의 글리시리진 제거방법.The porous resin adsorbent is glycerine-divinylbenzene, methacrylate and derivatives thereof, characterized in that at least one selected from the group consisting of glycyrrhizin of licorice.
  7. 감초를 열수 추출하는 제1차 추출단계; A first extraction step of extracting hot water from licorice;
    상기 제1차 추출하여 얻어진 감초와 추출액의 혼합물을 여과하여 감초를 분리하고 분리된 감초에 유기 용매를 가한 다음 가열하여 추출하는 제2차 추출단계; A second extraction step of filtering the mixture of licorice and extract obtained by the first extraction to separate licorice, adding an organic solvent to the separated licorice, and then heating and extracting it;
    상기 제2차 추출하여 얻어진 감초와 추출액의 혼합물을 여과하여 추출액을 분리한 후, 분리된 추출액을 소수성인 다공질의 레진 흡착제와 접촉시켜 약리 활성 유효성분을 흡착하는 흡착단계; 및 An adsorption step of filtering the mixture of licorice and extract obtained by the second extraction to separate the extract and then adsorbing the separated extract with a hydrophobic porous resin adsorbent to adsorb pharmacologically active ingredients; And
    상기 약리 활성 유효성분이 흡착된 다공질의 레진 흡착제를 용매와 접촉시켜 약리 활성 유효성분이 용매에 용해되도록 하여 분리시키는 탈착단계;를 포함하는 것을 특징으로 하는 감초 추출물의 제조방법.And a desorption step of separating the pharmacologically active active ingredient by dissolving the pharmacologically active active ingredient in contact with a solvent by contacting the porous resin adsorbent to which the pharmacologically active active ingredient is adsorbed.
  8. 제7항에 있어서, The method of claim 7, wherein
    상기 흡착단계는, 상기 제2차 추출에서 분리된 추출액에 희석 용매를 가하여 희석시킨 다음, 다공질의 레진 흡착제와 접촉시키는 것을 특징으로 하는 감초 추출물의 제조방법.The adsorption step, dilution by adding a dilution solvent to the extract separated in the second extraction, and then contacting with a porous resin adsorbent manufacturing method of licorice extract.
  9. 제7항에 있어서, The method of claim 7, wherein
    상기 흡착단계는,The adsorption step is
    (a) 상기 제2차 추출에서 분리된 추출액에 물을 가하여 희석시킨 다음, 다공질의 레진 흡착제와 제1차 접촉시키는 공정; 및 (a) adding water to and diluting the extract separated in the second extraction, followed by first contact with a porous resin adsorbent; And
    (b) 상기 제1차 접촉된 추출액에 30 ~ 60중량%의 에탄올 수용액을 가하여 희석시킨 다음, 다공질의 레진 흡착제와 제2차 접촉시키는 공정을 포함하는 것을 특징으로 하는 감초 추출물의 제조방법.(b) adding a dilute solution of 30 to 60% by weight of ethanol to the first contacted extract, followed by a second contact with a porous resin adsorbent for producing a licorice extract.
  10. 제7항에 있어서,The method of claim 7, wherein
    상기 흡착단계는, 다공질의 레진 흡착제가 충전된 컬럼에 추출액을 통과시켜 접촉시키는 것을 특징으로 하는 감초 추출물의 제조방법.The adsorption step, the licorice extract production method characterized in that the extract is passed through a column filled with a porous resin adsorbent.
  11. 제7항에 있어서,The method of claim 7, wherein
    상기 탈착단계는, 70 ~ 98중량%의 에탄올 수용액을 이용하여 다공질의 레진 흡착제로부터 약리활성 유효성분을 분리시키는 것을 특징으로 하는 감초 추출물의 제조방법.The desorption step, the licorice extract manufacturing method characterized in that to separate the pharmacologically active ingredient from the porous resin adsorbent using 70 ~ 98% by weight of ethanol aqueous solution.
  12. 제11항에 있어서, The method of claim 11,
    상기 탈착단계를 거친 추출액을 감압 하에서 30 ~ 100℃의 온도로 가열하여 농축하는 단계를 더 포함하는 것을 특징으로 하는 감초 추출물의 제조방법.Method of producing a licorice extract, characterized in that further comprising the step of condensing the extract after the desorption step to a temperature of 30 ~ 100 ℃ under reduced pressure.
  13. 제11항에 있어서, The method of claim 11,
    상기 탈착단계를 거친 감초 추출물을 감압 하에서 30 ~ 100℃의 온도로 가열하여 농축하는 단계; 및 Concentrating the licorice extract after the desorption step by heating to a temperature of 30 ~ 100 ℃ under reduced pressure; And
    상기 농축된 추출액에 부형제를 첨가하는 단계를 더 포함하는 것을 특징으로 하는 감초 추출물의 제조방법.Method for producing a licorice extract, characterized in that it further comprises the step of adding an excipient to the concentrated extract.
  14. 제7항에 있어서,The method of claim 7, wherein
    상기 다공질의 레진 흡착제는 스티렌-디비닐벤젠, 메타크릴레이트 및 이들의 유도체 중에서 선택된 하나 이상을 포함하는 것을 특징으로 하는 감초 추출물의 제조방법.The porous resin adsorbent is a method for producing licorice extract, characterized in that it comprises one or more selected from styrene-divinylbenzene, methacrylate and derivatives thereof.
  15. 제7항 내지 제14항 중 어느 하나의 항에 따른 제조방법으로 제조되고, 글리시리진의 함량이 1.0중량% 이하인 것을 특징으로 하는 감초 추출물.The licorice extract is prepared by the method according to any one of claims 7 to 14, characterized in that the content of glycyrizine is 1.0% by weight or less.
  16. 제15항에 따른 감초 추출물을 포함하는 것을 특징으로 하는 항충치 조성물.An anti-cavities composition comprising licorice extract according to claim 15.
PCT/KR2012/000766 2011-07-22 2012-01-31 Method for deglycyrrhizinating liquorice, deglycyrrhizinated liquorice extracts and method for preparing same, and anti-caries composition WO2013015504A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0073197 2011-07-22
KR1020110073197A KR101107237B1 (en) 2011-07-22 2011-07-22 Method for removing glycyrrhizin of liquorice, liquorice extract removed glycyrrhizin and method for manufacturing the same, and anti-cariogenic composition

Publications (1)

Publication Number Publication Date
WO2013015504A1 true WO2013015504A1 (en) 2013-01-31

Family

ID=45614493

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/000766 WO2013015504A1 (en) 2011-07-22 2012-01-31 Method for deglycyrrhizinating liquorice, deglycyrrhizinated liquorice extracts and method for preparing same, and anti-caries composition

Country Status (2)

Country Link
KR (1) KR101107237B1 (en)
WO (1) WO2013015504A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180091432A (en) * 2017-02-07 2018-08-16 로렌제릭 인코포레이티드 Method and system for removing substance which causes side effect from biological extract

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101581240B1 (en) * 2014-07-02 2015-12-31 (주) 노바렉스 Preparation method of extract of licorice containing Glycyrrhizic acid and Liquiritin
WO2016122262A1 (en) * 2015-01-29 2016-08-04 주식회사 덴트화이트 Method for preparing licorice extract, and composition for preventing or treating oral diseases comprising extract obtained therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4335091B2 (en) 2004-08-09 2009-09-30 海洋総合開発株式会社 Surveillance camera device

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DONG HO, SEO ET AL.: "Separation of Glycyrrhizin from Glycyrrhiza uralensis using Alumina Ultrafiltration Membrane", THE MEMBRANE SOCIETY OF KOREA, 1999, pages 106 - 108 *
IN-WOOK, CHOI ET AL.: "Anticariogenic Activities of Various Plant Extracts", KOREAN JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, vol. 35, no. 6, 2003, pages 1221 - 1225 *
MYUNG-HWA, KANG ET AL.: "Component Characteristics of Each Extract Prepared by Different Extract Methods from By-products of Glycyrrhizia uralensis", JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION, vol. 30, no. 1, 2001, pages 138 - 142 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180091432A (en) * 2017-02-07 2018-08-16 로렌제릭 인코포레이티드 Method and system for removing substance which causes side effect from biological extract
KR101949577B1 (en) 2017-02-07 2019-02-19 로렌제릭 인코포레이티드 Method and system for removing substance which causes side effect from biological extract

Also Published As

Publication number Publication date
KR101107237B1 (en) 2012-01-25

Similar Documents

Publication Publication Date Title
WO2010011020A1 (en) Method for preparing polysaccharide of green tea and cosmetic composition for skin whitening, moisturization and anti-wrinkle effects comprising the polysaccharide
WO2017104966A1 (en) Composition containing saponins of panax ginseng as active ingredient
WO2019103329A1 (en) Antioxidant composition comprising fermented mealworm extract as active ingredient
WO2019083321A2 (en) Composition for antioxidation, anti-inflammation, or osteoclast differentiation inhibition
WO2022086041A1 (en) Novel lactobacillus sp. strain and use thereof
WO2014069874A1 (en) Composition for removing keratinous skin material comprising green tea lactobacillus
WO2016003063A1 (en) Method for preparing ginseng polysaccharides for immune enhancement and ginseng polysaccharides for immune enhancement prepared by same preparation method
WO2013015504A1 (en) Method for deglycyrrhizinating liquorice, deglycyrrhizinated liquorice extracts and method for preparing same, and anti-caries composition
WO2014003356A1 (en) Method for preparing extract of vegetable worm culture mycelium solution containing cordycepin in high concentration, and composition for treating or preventing vascular diseases, containing said extract
WO2019098518A1 (en) Method for preparing green tea extract and green tea extract prepared therefrom
WO2014208888A1 (en) Composition for preventing and treating gastrointestinal diseases, containing essential oils extracted from litsea japonica fruit
KR20040099300A (en) Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
WO2018026103A1 (en) Composition for cell regeneration comprising ginseng floral axis extract
WO2010058982A2 (en) Antioxidant cosmetic composition containing extract of processed peony, polygonati rhizoma or lily
WO2011126322A2 (en) Composition for treating or preventing degenerative cranial nerve diseases, containing black bean extract
WO2017003086A1 (en) Composition for inhibiting and preventing myopathy, containing bean leaf extract as active ingredient
WO2024005561A1 (en) Composition comprising stewartia pseudocamellia extract as active ingredient for prevention or treatment of dementia
WO2018135912A2 (en) Composition comprising curcumin-captured ginsenoside and phospholipid-based lipid nanoparticle as effective ingredient for preventing or treating helicobacter pylori infection
WO2018062752A1 (en) Catechin absorption enhancer for enhancing catechin absorption in small intestinal epithelial cells
WO2020101414A1 (en) Composition for promoting skin regeneration and hair growth, containing apigenin
WO2019139403A1 (en) Composition containing sericin, torilis japonica extract, and viscum album extract for skin generation, skin soothing, or wound healing
WO2017209397A1 (en) Composition for enhancing absorption of fat-soluble vitamins
KR100454226B1 (en) Processing method of licorice extract and its&#39; utilization on developing anti-cariogenic products
WO2022139529A1 (en) Composition for preventing, improving or treating gastritis or peptic ulcer comprising extract of cinnamomum cassia, fraction of said extract, isolate of said fraction or compounds isolated therefrom
WO2021177657A1 (en) Dna aptamer specifically binding to glutathione and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12817924

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 04/06/2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12817924

Country of ref document: EP

Kind code of ref document: A1